rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTAGACTAGCGGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSPRLAGPTDTQYF	In	VDJ	7	358	0.010252885413981729	0.013444999436662036	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	2	3	2	4	2	23	35	50	39	52			01,02										Vb 1	CASSPRLAGPTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGAAGGACAGGGTCGAAAACATTCAGTACTTCGGCGCC	CASRKDRVENIQYF	In	VDJ	1	44	0.0012601311681988716	0.0016524580313215908	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	1	3	5	3	3	23	34	45	37	48			01,02										Vb 1	CASRKDRVENIQYF+TCRBV09-01+TCRBJ02-04	TCRBV09-01	TCRBD01-01*01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAACGCCGCCGGGGCGAGCTCCTACGAGCAGTACTTCGGGCCG	CASNAAGASSYEQYF	In	VDJ	1	33	9.450983761491537E-4	0.001239343523491193	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	6	7	0	0	8	3	23	33	46	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASNAAGASSYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGGCCGGGGTACGGCAGATACGCAGTATTTTGGCCCA	CASSGRGTADTQYF	In	VDJ	1	32	9.164590314173611E-4	0.0012017876591429752	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	3	4	4	5	23	34	43	38	48			01,02										Vb 1	CASSGRGTADTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAACCCCACACTGAAGCTTTCTTTGGACAA	CASSVEPHTEAFF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	0	3	7	3	1	3	23	39	42	40	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVEPHTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAAGAGACAGGCCCGGAAACACCATATATTTTGGAGAG	CASSVRDRPGNTIYF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	2	4	4	3	3	23	38	47	41	50			01,02										Vb 1	CASSVRDRPGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD01-01*01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCCCCGTGAAGGGGTCGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	25	7.159836182948135E-4		49	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	1	8	2	23	37	50	45	52			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGTATATAAGACGGGGGTCGAAGCTTTCTTTGGACAA	CASSVYKTGVEAFF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	2	8	7	2	23	38	51	45	53			01,02										Vb 1	CASSVYKTGVEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGCCCCGGGGACTAGCGGGGGACAACACCGGGGAGCTGTTTTTTGGAGAA	CASRPRGLAGDNTGELFF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	54	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	0	2	2	6	2	23	34	54	40	56			01,02										Vb 1	CASRPRGLAGDNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCGGGACTAGCGGGGGCTACGGTCCATACAATGAGCAGTTCTTCGGGCCA	CASSVGTSGGYGPYNEQFF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	57	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	0	2	4	1	10	23	37	52	38	62			01,02										Vb 1	CASSVGTSGGYGPYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGAGAGAGGACAGAAACTATGGCTACACCTTCGGTTCG	CASRREDRNYGYTF	In	VDJ	1	21	6.014262393676433E-4	7.886731513125774E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	5	2	6	1	23	34	46	40	47			01,02										Vb 1	CASRREDRNYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAATCGGTAGCGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSESVAGSSYNEQFF	In	VDJ	1	20	5.727868946358507E-4	7.511172869643594E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	3	0	8	2	23	34	50	42	52			01,02										Vb 1	CASSESVAGSSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTTGGACAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFGQNTGELFF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	42	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	6	1	1	0	19	33	-1	34	39														CASSFGQNTGELFF+TCRBV11-01+TCRBJ02-02	TCRBV11-01*01	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTCGCCAGGACAGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSSPGQGSYEQYF	In	VDJ	1	21	6.014262393676433E-4	7.886731513125774E-4	45	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	2	1	5	0	19	32	-1	37	46														CASSSPGQGSYEQYF+TCRBV11-01+TCRBJ02-07	TCRBV11-01*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCCTCCGGGGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	92	0.0026348197153249135		43	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	8	2	2	4	0	29	45	-1	49	55													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTAACTCAGGGGCTACGAGCAGTACTTCGGGCCG	CASS*LRGYEQYF	Stop	VDJ	2	87	0.0024916229916659505		39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	3	5	0	29	41	-1	46	52													Vb 16	CASS*LRGYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTCCCGGGCGACTGCTGAAGCTTTCTTTGGACAA	CASSSRATAEAFF	In	VDJ	1	65	0.0018615574075665148	0.0024411311826341682	39	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	5	8	0	6	4	5	29	41	49	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSSRATAEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATTCCGTTCTACAATGAGCAGTTCTTTGGGCCA		Out	VDJ	1	60	0.0017183606839075523		43	TCRBV14	TCRBV14-01	01				TCRBJ02			0	3	6	22	9	14	29	46	58	55	72				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05					Vb 16	X+TCRBV14-01+TCRBJ02-X	TCRBV14-01*01		TCRBJ02	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATACTCGTAATCTGGAAACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	56	0.001603803304980382		49	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	2	1	8	4	12	3	29	44	59	56	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACCCGCCGCCTTTACTGGAAACACCATATATTTTGGAGAG	CASSQPAAFTGNTIYF	In	VDJ	1	53	0.0015178852707850045	0.001990460810455553	48	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-03	01	2	10	0	2	3	8	29	44	49	47	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQPAAFTGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01		TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTGCTCAGGGGGATGGTTTGTGACCCAGTACTTCGGGCCA		Out	VDJ	1	52	0.001489245926053212		49	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	1	7	4	9	29	45	56	49	65													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCTTACAGGGAGACGGGAGTACGAGCAGTACTTCGGGCCG	CASSLTGRREYEQYF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	45	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	6	3	3	4	4	9	29	40	50	44	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSLTGRREYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGGGGTGGCAGAATATGGCTACACCTTCGGTTCG	CASSQDGVAEYGYTF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	45	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	0	6	2	5	1	8	29	46	51	47	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDGVAEYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAAGGCCTAGAGGGTCGTCCAGATACGCAGTATTTTGGCCCA	CASSVEGLEGRPDTQYF	In	VDJ	1	51	0.0014606065813214193	0.0019153490817591166	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	0	4	12	5	24	36	53	48	58														CASSVEGLEGRPDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGGGGAATCGGAAGGAAAAACTGTTTTTTGGCAGT	CASSVGGNRKEKLFF	In	VDJ	1	45	0.0012887705129306642	0.001690013895669809	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-04	01	5	5	1	8	2	10	24	36	44	38	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGGNRKEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01		TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTACGGGGGAACTATAATTCACCCCTCCACTTTGGGAAC	CASSVRGNYNSPLHF	In	VDJ	1	36	0.0010310164103445314	0.0013520111165358471	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	5	8	2	3	3	2	24	36	45	39	47														CASSVRGNYNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCAGCGGGGCAATGAGAACACTGAAGCTTTCTTTGGACAA	CASSQRGNENTEAFF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	6	3	1	1	6	24	36	44	37	50														CASSQRGNENTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTCGATAAGACAGGGGCCTACGAGCAGTACTTCGGGCCG	CASSVDKTGAYEQYF	In	VDJ	1	28	8.01901652490191E-4	0.0010515642017501032	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	2	2	8	0	24	36	-1	44	52														CASSVDKTGAYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAGGACCACGGGGGCGACTGAACACTGAAGCTTTCTTTGGACAA	CASSLGPRGRLNTEAFF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	51	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	6	6	0	0	11	3	24	35	52	46	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPRGRLNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACACCGTTGAAAGGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	5.727868946358507E-4		46	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	4	5	4	0	10	0	24	37	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAATTTTGACCGGTCGGGCTACACCTTCGGTTCG	CASNFDRSGYTF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	10	2	7	8	8	6	24	31	42	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNFDRSGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCCCCTGGCTAAAGGGAACTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	17	4.868688604404731E-4		47	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-06	01	10	0	8	3	13	1	24	31	48	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01		TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGGGGACTTTTCGATACGCAGTATTTTGGCCCA	CASSLGGLFDTQYF	In	VDJ	1	59	0.0016897213391757597	0.0022157959965448605	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	0	10	6	1	4	18	34	41	35	45						01,02								CASSLGGLFDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTTTGACACTTAATTCACCCCTCCACTTTGGGAAC	CASSFLTLNSPLHF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	6	6	3	2	18	32	39	35	41														CASSFLTLNSPLHF+TCRBV07-06+TCRBJ01-06	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCCACCCTCCCGGGGAACCAGCCCCAGCATTTTGGTGAT	CASSPTLPGNQPQHF	In	VDJ	1	33	9.450983761491537E-4	0.001239343523491193	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	3	7	10	3	18	30	45	40	48														CASSPTLPGNQPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD02-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCAACAGGGCCCCAAGATTCGGCTTTCTTTGGACAA	CASSSTGPQDSAFF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	11	2	12	18	31	39	33	51														CASSSTGPQDSAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGAGACAGGGGGGTCGAGCACTGAAGCTTTTTTTGGACAA	CASSLETGGSSTEAFF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	1	17	1	19	18	34	44	35	63														CASSLETGGSSTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTATCCAGGGGTCAGAGACCCAGTACTTCGGGCCA	CASSFIQGSETQYF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	2	4	4	2	18	32	42	36	44														CASSFIQGSETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGGAAGGGACGGCAAGAGACCCAGTACTTCGGGCCA	CASSLGKGRQETQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	45	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-05	01	1	0	7	2	4	2	18	34	43	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGKGRQETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01		TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGACGGTAATAATCAGCCCCAGCATTTTGGTGAT	CASSLDGNNQPQHF	In	VDJ	1	37	0.0010596557550763238	0.001389566980884065	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	8	5	4	1	4	19	35	39	36	43						01,02								CASSLDGNNQPQHF+TCRBV07-05+TCRBJ01-05	TCRBV07-05*01	TCRBD02-01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCCCGGACTAGCAACAATGAGCAGTTCTTCGGGCCA	CASSPRTSNNEQFF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	7	5	4	1	19	31	43	35	44						01,02								CASSPRTSNNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGTTTGGCGGGTAGCGGGGGCCTTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	5.727868946358507E-4		52	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	5	2	3	12	4	19	27	48	39	52														X+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGACAGGGGGCTGGAAACACCATATATTTTGGAGAG	CASSLGQGAGNTIYF	In	VDJ	1	20	5.727868946358507E-4	7.511172869643594E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	1	2	0	0	19	-1	-1	35	44														CASSLGQGAGNTIYF+TCRBV07-05+TCRBJ01-03	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTACCGGGACAGGTTACACGAGCAGTACTTCGGGCCG	CASSYRDRLHEQYF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	5	3	4	19	32	43	35	47														CASSYRDRLHEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTCGGGCGGGGGGGCAAAGAGACCCAGTACTTCGGGCCA	CASSFGRGGKETQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	7	0	3	3	2	19	33	45	36	47														CASSFGRGGKETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCGTTGACAGGGAGGACAGATACGCAGTATTTTGGCCCA	CASSLALTGRTDTQYF	In	VDJ	1	51	0.0014606065813214193	0.0019153490817591166	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	3	3	4	3	19	35	46	39	49													Vb 5.1	CASSLALTGRTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGCCAGCGCGGGCCAGTCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLPARASLAKNIQYF	In	VDJ	1	48	0.0013746885471260417	0.0018026814887144628	54	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	1	7	4	0	5	7	19	34	44	39	51						01,02							Vb 5.1	CASSLPARASLAKNIQYF+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD02-01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCCCGACAGGGGGAGATCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLPTGGDLAKNIQYF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	54	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	2	1	0	5	6	19	31	45	36	51													Vb 5.1	CASSLPTGGDLAKNIQYF+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCCCGACAGGGCGCACAGATACGCAGTATTTTGGCCCA	CASSLAPTGRTDTQYF	In	VDJ	1	34	9.737377208809462E-4	0.0012768993878394112	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	3	1	4	1	19	35	46	39	47													Vb 5.1	CASSLAPTGRTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGCCCTCCTCCCGGACAGACCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLPSSRTDLAKNIQYF	In	VDJ	1	31	8.878196866855686E-4	0.0011642317947947573	57	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	1	5	0	10	4	19	34	50	44	54													Vb 5.1	CASSLPSSRTDLAKNIQYF+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGTCGGGGCGAGAACACTGAAGCTTTCTTTGGACAA	CASSLGRGENTEAFF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	0	7	0	1	3	2	19	35	43	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGRGENTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAAGGRGACAGGGATGACCGGGGAGCTGTTTTTTGGAGAA	CASKXTGMTGELFF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	5	2	3	19	29	40	31	43													Vb 5.1	CASKXTGMTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGCAGGGACAGGGGTACTCCTACGAGCAGTACTTCGGGCCG	CASSLQGQGYSYEQYF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	0	2	2	19	34	46	36	48													Vb 5.1	CASSLQGQGYSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGGCGGGGGCGCATGGTATGGCTACACCTTCGGTTCG	CASSPGGGAWYGYTF	In	VDJ	1	60	0.0017183606839075523	0.0022533518608930784	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	7	2	5	4	7	25	37	48	41	55													Vb 3	CASSPGGGAWYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGTTAGCCGCCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVSRLSYNEQFF	In	VDJ	1	47	0.0013460492023942491	0.0017651256243662449	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	7	0	2	5	25	37	43	39	48						01,02							Vb 3	CASSVSRLSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGACAGGGAGTCCAAGAGACCCAGTACTTCGGGCCA	CASSLGQGVQETQYF	In	VDJ	1	39	0.001116934444539909	0.001464678709580501	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	3	1	0	3	25	-1	48	39	51													Vb 3	CASSLGQGVQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCACAGGGACTATGGCTACACCTTCGGTTCG	CASSHRDYGYTF	In	VDJ	1	26	7.44622963026606E-4	9.764524730536674E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	3	1	0	25	37	-1	38	44													Vb 3	CASSHRDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATGACAGGGGGACACAATGAGCAGTTCTTCGGGCCA	CASSMTGGHNEQFF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	1	5	2	2	25	37	48	39	50													Vb 3	CASSMTGGHNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGCCATCAGGGAGACTATGGCTACACCTTCGGTTCG	CASGHQGDYGYTF	In	VDJ	1	20	5.727868946358507E-4	7.511172869643594E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	8	4	3	3	6	2	25	34	45	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASGHQGDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAGGCCTGAGCGGGGCACTTTACGAGCAGTACTTCGGGCCG	CASSEGLSGALYEQYF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	6	3	4	5	5	24	40	52	45	57														CASSEGLSGALYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEGGSGANVLTF	In	VDJ	1	20	5.727868946358507E-4	7.511172869643594E-4	45	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-06	01	1	6	1	1	0	0	23	-1	-1	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGGSGANVLTF+TCRBV06-01+TCRBJ02-06	TCRBV06-01*01		TCRBJ02-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTCCCGGCTACGAGCAGTACTTCGGGCCG	CASSEAPGYEQYF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	39	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	8	5	3	3	0	23	40	-1	43	46						01,02								CASSEAPGYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGACGCTAGCGGCGCCTACGAGCAGTACTTCGGGCCG	CASSEDASGAYEQYF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	5	2	3	2	23	39	49	42	51						01,02								CASSEDASGAYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAGCTAGCGGGGGGGCAGATACGCAGTATTTTGGCCCA	CASSEASGGADTQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	5	0	4	0	0	24	-1	-1	41	52														CASSEASGGADTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCCCCAGCCGGGACACCGGGGAGCTGTTTTTTGGAGAA	CAWSPPSRDTGELFF	In	VDJ	2	120	0.0034367213678151045	0.004506703721786157	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	8	4	3	9	0	26	38	-1	47	51			unresolved			01,02							Vb 20	CAWSPPSRDTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCGGGGCTACAGGGAATCACTGAAGCTTTCTTTGGACAA	CASGLQGITEAFF	In	VDJ	2	108	0.003093049231033594	0.004056033349607541	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	4	7	3	26	33	46	40	49			unresolved										Vb 20	CASGLQGITEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGAGGACCAGCCCCAGCATTTTGGTGAT	CAWGEDQPQHF	In	VDJ	2	85	0.0024343443022023657	0.003192248469598528	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	9	1	7	1	2	26	35	42	36	44													Vb 20	CAWGEDQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACTCGGACAGGGGCATACCATATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	77	0.0022052295443480254		55	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	2	0	4	9	26	37	50	41	59													Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCCAAGACAGGGGACTTAGCACAGATACGCAGTATTTTGGCCCA	CAQDRGLSTDTQYF	In	VDJ	1	65	0.0018615574075665148	0.0024411311826341682	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	2	2	0	3	4	26	32	43	35	47													Vb 20	CAQDRGLSTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGCAGGGAGGGAAACTGAAGCTTTCTTTGGACAA	CAWSAGRETEAFF	In	VDJ	1	63	0.0018042787181029299	0.0023660194539377325	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	0	5	4	2	26	37	48	41	50			unresolved										Vb 20	CAWSAGRETEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGACAGTTCCTCCTCCCAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	59	0.0016897213391757597		49	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	5	1	1	11	26	35	43	36	54			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGTTTACAGGGGGCTCAACTATGGCTACACCTTCGGTTCG	CAWRVYRGLNYGYTF	In	VDJ	1	58	0.001661081994443967	0.0021782401321966426	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	0	2	5	2	26	37	51	42	53													Vb 20	CAWRVYRGLNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACAGGGTTGTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	55	0.0015751639602485895		37	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	4	3	6	0	3	26	-1	41	36	44													Vb 20	X+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGTCCCTATGGACTGAAGCTTTCTTTGGACAA	CAWSGSLWTEAFF	In	VDJ	1	49	0.0014033278918578343	0.0018402373530626806	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	4	9	5	5	3	26	39	47	44	50						01,02							Vb 20	CAWSGSLWTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATGGCAGGACAATCAGCCCCAGCATTTTGGTGAT	CAWSVWQDNQPQHF	In	VDJ	1	45	0.0012887705129306642	0.001690013895669809	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	4	3	4	1	26	40	48	44	49													Vb 20	CAWSVWQDNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATGCAGGGTCCCTCGGGTCACCCCTCCACTTTGGGAAC	CAWNAGSLGSPLHF	In	VDJ	1	43	0.0012314918234670792	0.001614902166973373	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	4	3	10	3	9	26	36	44	39	53			unresolved										Vb 20	CAWNAGSLGSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCGGGACAGGGGGCGAATGGCTACACCTTCGGTTCG	CAWSPGQGANGYTF	In	VDJ	1	42	0.0012028524787352866	0.0015773463026251548	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	0	6	3	2	26	37	52	40	54			unresolved										Vb 20	CAWSPGQGANGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGCCGGATGAATTCACCCCTCCACTTTGGGAAC	CAWGRMNSPLHF	In	VDJ	1	39	0.001116934444539909	0.001464678709580501	36	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-06	01	5	1	8	7	4	2	26	35	42	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWGRMNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02		TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAAATTGGGTCACCCCTCCACTTTGGGAAC	CAWKIGSPLHF	In	VDJ	1	37	0.0010596557550763238	0.001389566980884065	33	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-06	01	4	0	9	10	5	0	26	36	-1	41	44			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKIGSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02		TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCAGCGGTCAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASGQGNTGELFF	In	VDJ	1	37	0.0010596557550763238	0.001389566980884065	39	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-02	01	8	4	3	1	6	0	26	32	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CASGQGNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02		TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATTGGGGGACCTTACCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	7.159836182948135E-4		44	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	4	0	7	0	4	5	26	36	45	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCCCCGTGGACAGGGAGAATCAGCCCCAGCATTTTGGTGAT	CAWSPPVDRENQPQHF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	3	4	8	2	26	38	54	46	56													Vb 20	CAWSPPVDRENQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACAAAAAACACCATATATTTTGGAGAG	CAWSTKNTIYF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	3	6	6	0	2	26	-1	41	38	43													Vb 20	CAWSTKNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCTTGGACGAACAGGGGTTGGATCTAGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	22	6.300655840994358E-4		47	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	2	4	3	9	26	36	46	39	55			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCCGAGCTTGTGTTATAGAAAGACCTATGGCTACACCTTCGGTTCG	CAWPSLCYRKTYGYTF	In	VDJ	1	21	6.014262393676433E-4	7.886731513125774E-4	48	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-02	01	5	2	7	4	20	0	26	35	-1	55	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWPSLCYRKTYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTCACCAGCGGGGTGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSQVTSGVPYNEQFF	In	VDJ	1	63	0.0018042787181029299	0.0023660194539377325	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	6	3	2	5	3	23	39	51	44	54														CASSQVTSGVPYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATACCCCCCCCGTGGGTCCGTTTTTTGGCAGT	CASSQDTPPVGPFF	In	VDJ	1	61	0.0017470000286393447	0.0022909077252412963	42	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-04	01	0	0	9	16	12	3	23	40	55	52	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDTPPVGPFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01		TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCTACTCCGGGACAGGCACCTACGAGCAGTACTTCGGGCCG	CASSYSGTGTYEQYF	In	VDJ	1	52	0.001489245926053212	0.0019529049461073347	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	2	6	2	23	35	49	41	51														CASSYSGTGTYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAACCAAGATCAAGCGGGACAGGGAGTTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	50	0.001431967236589627		52	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	3	4	6	4	23	40	55	46	59														X+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGCGGCCGGGGCTTTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	44	0.0012601311681988716		49	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-03	01	1	7	0	1	5	3	23	39	49	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01		TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCACGGAATATGGAATGGGGGAGAACGCTATAATTCACCCCTCCACTTTGGGAAC	CASSHGIWNGGERYNSPLHF	In	VDJ	1	43	0.0012314918234670792	0.001614902166973373	60	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-06	01	3	6	1	3	13	6	21	35	53	48	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHGIWNGGERYNSPLHF+TCRBV01-01+TCRBJ01-06	TCRBV01-01*01		TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCAGGACAGGGAGAGGGGTATGAGCAGTTCTTCGGGCCA	CASSPGQGEGYEQFF	In	VDJ	1	37	0.0010596557550763238	0.001389566980884065	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	3	8	2	8	23	36	46	38	54														CASSPGQGEGYEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGGCAGAGGGAACACTGAAGCTTTCTTTGGACAA	CASSQGRGNTEAFF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	42	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	3	8	0	1	0	5	23	-1	41	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGRGNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGTCCGAGATTAAGCGGGGGGGGCCTAAATGAGCAGTTCTTCGGGCCA	CASSPRLSGGGLNEQFF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	0	7	10	5	23	34	54	44	59														CASSPRLSGGGLNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGATGATGGGACTAGCGGGGGGTTGGGCGCAGATACGCAGTATTTTGGCCCA	CTSSQDDGTSGGLGADTQYF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	60	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	0	1	4	4	7	21	38	57	42	64														CTSSQDDGTSGGLGADTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCTTGGGAGGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPLGGGTGELFF	In	VDJ	1	21	6.014262393676433E-4	7.886731513125774E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	9	1	4	4	3	23	36	46	40	49														CASSPLGGGTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACCACAGGGCCACCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	5.727868946358507E-4		46	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	3	2	2	5	23	38	46	40	51														X+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCTTAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	20	5.727868946358507E-4		40	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-06	01	5	5	5	5	4	2	23	35	41	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01		TCRBJ02-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCAGCGGGGACTCCTGGAGATACGCAGTATTTTGGCCCA	CASSQAAGTPGDTQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	6	3	5	1	8	23	39	47	40	55														CASSQAAGTPGDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGGCAGTTTCTATGGCTACACCTTCGGTTCG	CASSLGSFYGYTF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	39	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-02	01	4	4	5	4	4	3	22	35	42	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSFYGYTF+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCCTTGCGGGAACAAGAGACCCAGTACTTCGGGCCA	CASSPLREQETQYF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	42	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	7	3	2	5	1	22	34	45	39	46														CASSPLREQETQYF+TCRBV07-01+TCRBJ02-05	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTGGATGCCCAAGGGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	5.441475499040582E-4		50	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-03	01	4	5	1	1	10	1	22	35	51	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01		TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGCGGGGGATTCTAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSAGDSSSGANVLTF	In	VDJ	1	44	0.0012601311681988716	0.0016524580313215908	51	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	4	8	2	0	0	7	23	-1	42	36	49													Vb 12	CASSAGDSSSGANVLTF+TCRBV10-02+TCRBJ02-06	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACCATCCCGGGACAGGGCCCCTACGAGCAGTACTTCGGGCCG	CASTIPGQGPYEQYF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	3	2	7	2	23	33	49	40	51													Vb 12	CASTIPGQGPYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGATGGAAACACTGAAGCTTTCTTTGGACAA	CASSEDGNTEAFF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	2	1	8	2	3	0	23	38	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEDGNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGTCCCGGGGTTCAGGTGAAAAACTGTTTTTTGGCAGT	CAISESSRGSGEKLFF	In	VDJ	5	277	0.007933098490706532	0.010402974424456379	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	8	3	7	4	6	23	40	49	44	55													Vb 12	CAISESSRGSGEKLFF+TCRBV10-03+TCRBJ01-04	TCRBV10-03*01	TCRBD02-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCAGGGGAAGGCTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAISESGEGFSGANVLTF	In	VDJ	1	59	0.0016897213391757597	0.0022157959965448605	54	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	5	2	0	0	7	23	-1	45	40	52													Vb 12	CAISESGEGFSGANVLTF+TCRBV10-03+TCRBJ02-06	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGAGAGACTAGCGGTAGCACAGATACGCAGTATTTTGGCCCA	CASRETSGSTDTQYF	In	VDJ	1	40	0.0011455737892717014	0.0015022345739287189	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	3	5	0	0	1	24	-1	47	39	48						01,02							Vb 12	CASRETSGSTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGCGTGGAGCTGGCTACACCTTCGGTTCG	CAISERGAGYTF	In	VDJ	1	33	9.450983761491537E-4	0.001239343523491193	36	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	10	2	7	3	1	23	38	45	41	46													Vb 12	CAISERGAGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD02-01*02	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGTCGGTCGAAGGGGACACTGAAGCTTTCTTTGGACAA	CASSESVEGDTEAFF	In	VDJ	1	27	7.732623077583984E-4	0.0010140083374018853	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	3	6	0	24	41	-1	47	52													Vb 12	CASSESVEGDTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGATGCGGCCGAATGAAAAACTGTTTTTTGGCAGT	CAISEMRPNEKLFF	In	VDJ	1	26	7.44622963026606E-4	9.764524730536674E-4	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	7	5	5	2	3	23	38	44	40	47						01,02							Vb 12	CAISEMRPNEKLFF+TCRBV10-03+TCRBJ01-04	TCRBV10-03*01	TCRBD02-01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGACAGGGGAAACACTGAAGCTTTCTTTGGACAA	CAISESDRGNTEAFF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	2	2	0	1	23	-1	49	40	50													Vb 12	CAISESDRGNTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGAAGTTGCGGGGGGGCGTGGCACAGATACGCAGTATTTTGGCCCA	CAISEVAGGRGTDTQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	51	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	0	1	4	4	24	38	51	42	55													Vb 12	CAISEVAGGRGTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTGGACATTATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	14	749	0.02145086920411261		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	6	0	2	3	27	41	48	43	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCCGGCGGGCCACAATGAGCAGTTCTTCGGGCCA	CASSIPAGHNEQFF	In	VDJ	6	327	0.00936506572729616	0.012280767641867278	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	7	4	5	4	2	27	41	50	45	52			01,02			01,02							Vb 17	CASSIPAGHNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTGGTGGTGACGAATGAGCAGTTCTTCGGGCCA	CASSLVVTNEQFF	In	VDJ	5	257	0.007360311596070682	0.00965185713749202	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	6	2	7	7	9	1	27	38	50	47	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLVVTNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTGGCGGGGACGTACATGGCTACACCTTCGGTTCG	CASIGGDVHGYTF	In	VDJ	4	239	0.006844803390898416	0.008975851579224096	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	7	3	6	3	6	27	37	46	40	52			01,02										Vb 17	CASIGGDVHGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGGGATTTAGACGAATCGCACAGATACGCAGTATTTTGGCCCA	CASSIEGI*TNRTDTQYF	Stop	VDJ	4	232	0.006644327977775868		54	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	0	0	8	1	1	12	27	44	49	45	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEGI*TNRTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGAGCCCAGTTGGGGTACGAGCAGTACTTCGGGCCG	CASRAQLGYEQYF	In	VDJ	3	146	0.00418134433084171	0.005483156194839824	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	8	6	2	4	11	0	27	36	-1	47	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRAQLGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCAGACAAAGGACACGCGAGAAAAACTGTTTTTTGGCAGT	CATQTKDTREKLFF	In	VDJ	2	129	0.003694475470401237	0.004844706500920119	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	1	6	8	10	5	27	34	49	44	54			01,02										Vb 17	CATQTKDTREKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAAGGAGATCAGTGGGAAACTGTTTTTTGGCAGT	CASSIKEISGKLFF	In	VDJ	2	115	0.0032935246441561416	0.004318924400045067	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	10	2	11	2	9	27	42	48	44	57			01,02										Vb 17	CASSIKEISGKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCAGCGGACAGGGTAACAATGAGCAGTTCTTCGGGCCA	CASSTSGQGNNEQFF	In	VDJ	2	108	0.003093049231033594	0.004056033349607541	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	3	5	5	2	27	40	53	45	55			01,02										Vb 17	CASSTSGQGNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTTGGGACATAGATACGCAGTATTTTGGCCCA	CASSPWDIDTQYF	In	VDJ	2	98	0.0028066557837156687	0.0036804747061253613	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	6	5	4	1	27	39	49	43	50			01,02										Vb 17	CASSPWDIDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGGCAGGCTGGAGAGACCCAGTACTTCGGGCCA	CASRQAGETQYF	In	VDJ	2	98	0.0028066557837156687	0.0036804747061253613	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	4	4	4	4	4	27	35	43	39	47			01,02										Vb 17	CASRQAGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGGGACACCTACACCGGGGAGCTGTTTTTTGGAGAA	CASSIRDTYTGELFF	In	VDJ	2	91	0.002606180370593121	0.0034175836556878357	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	6	3	2	3	27	41	49	43	52			01,02										Vb 17	CASSIRDTYTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGGGACCAACTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIRDQLSYNEQFF	In	VDJ	2	90	0.0025775410258613283	0.003380027791339618	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	0	7	0	2	5	27	41	48	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRDQLSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGGACCCATTGGCGGGGGAATCTCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	86	0.0024629836469341583		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	11	7	2	2	10	6	27	33	50	43	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTGGGGGAGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGEAYNEQFF	In	VDJ	2	84	0.002405704957470573	0.0031546926052503097	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	1	2	4	0	27	39	-1	43	49			01,02										Vb 17	CASSLGEAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTTTCGGCCAGGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	83	0.0023770656127387805		38	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	3	2	7	0	27	36	-1	43	48			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTCCGACAGGCACTCTGGAAACACCATATATTTTGGAGAG	CASSDRHSGNTIYF	In	VDJ	1	82	0.002348426268006988	0.003079580876553874	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	9	2	4	0	4	2	27	35	45	39	47			01,02										Vb 17	CASSDRHSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGGCGGTCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	81	0.0023197869232751953		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	7	5	2	2	1	27	44	50	46	51			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCCCCTTAACAGGGATGGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	78	0.002233868889079818		53	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	3	1	8	4	27	44	58	52	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCGGGACTAGCGGGGATTACAATGAGCAGTTCTTCGGGCCA	CATGTSGDYNEQFF	In	VDJ	1	78	0.002233868889079818	0.002929357419161002	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	0	3	4	2	2	27	34	49	36	51			01,02										Vb 17	CATGTSGDYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGAGTAGCGGGGTCGAGACCCAGTACTTCGGGCCA	CASSIGSSGVETQYF	In	VDJ	1	77	0.0022052295443480254	0.002891801554812784	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	5	3	5	4	2	27	43	55	47	57			01,02										Vb 17	CASSIGSSGVETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACAGGGATCTAATGAAAAACTGTTTTTTGGCAGT	CASSIQGSNEKLFF	In	VDJ	1	75	0.00214795085488444	0.002816689826116348	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	3	3	0	2	27	-1	47	42	49			01,02										Vb 17	CASSIQGSNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCCAGGAGGGGTCGAGACCCAGTACTTCGGGCCA	CASSAPGGVETQYF	In	VDJ	1	74	0.0021193115101526476	0.00277913396176813	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	10	0	5	6	3	27	39	51	45	54			01,02										Vb 17	CASSAPGGVETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGGGACAGGGATCTGAAAAACTGTTTTTTGGCAGT	CASSSGQGSEKLFF	In	VDJ	1	69	0.001976114786493685	0.00259135464002704	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	7	2	3	27	39	50	41	53			01,02										Vb 17	CASSSGQGSEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGCTTTCTATCTCTGTGCCAGTAGTGCCCGCTAGCGGGGGGGCCCTAACAGCTCCTACAATAAGCAGTTCTTCGGGCCA	CASSAR*RGGPNSSYNKQFF	Stop	VDJ	1	64	0.0018329180628347222		60	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	11	5	20	14	26	43	31	63			01,02										Vb 17	CASSAR*RGGPNSSYNKQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAGACAGCCTTACAGATACGCAGTATTTTGGCCCA	CASKDSLTDTQYF	In	VDJ	1	63	0.0018042787181029299	0.0023660194539377325	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	2	5	3	2	4	27	37	44	39	48			01,02										Vb 17	CASKDSLTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGGGGTACAGGGGCGGGAAAAACTGTTTTTTGGCAGT	CASSTGVQGREKLFF	In	VDJ	1	61	0.0017470000286393447	0.0022909077252412963	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	2	8	7	3	27	40	54	47	57			01,02										Vb 17	CASSTGVQGREKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTCCGACAGCCAGGAGGGGAGAACAGATACGCAGTATTTTGGCCCA	CASDSQEGRTDTQYF	In	VDJ	1	59	0.0016897213391757597	0.0022157959965448605	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	10	0	3	11	4	27	33	50	44	54			01,02										Vb 17	CASDSQEGRTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCTAATAGGTGGAGGGGGCTATGCGAATCAGCCCCAGCATTTTGGTGAT	CASLIGGGGYANQPQHF	In	VDJ	1	59	0.0016897213391757597	0.0022157959965448605	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	5	0	4	12	6	27	35	54	47	60			01,02										Vb 17	CASLIGGGGYANQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACGGGGGCAGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	58	0.001661081994443967		38	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	7	6	0	2	2	2	27	37	45	39	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATGTGAGGAGCGGGGGGGCCGTAGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	57	0.0016324426497121747		53	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	6	0	4	7	7	27	37	54	44	61			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAAGGATGATTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	57	0.0016324426497121747		47	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	3	1	8	0	3	5	27	41	47	44	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATARATGGAGCAAGGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSIXGARGTNEKLFF	In	VDJ	1	56	0.001603803304980382	0.0021031284035002065	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	2	1	7	0	27	44	-1	51	56			01,02										Vb 17	CASSIXGARGTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGGGGCTTCGGCAGAGCTATGGCTACACCTTCGGTTCG	CASSTGLRQSYGYTF	In	VDJ	1	55	0.0015751639602485895	0.0020655725391519886	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	4	7	0	4	1	10	27	40	46	41	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTGLRQSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCACAGGGGAGGGGAGCTGTTTTTTGGAGAA	CASSSHRGGELFF	In	VDJ	1	53	0.0015178852707850045	0.001990460810455553	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	2	8	4	1	27	39	50	43	51			01,02										Vb 17	CASSSHRGGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAACCGAGAGTGGGGCACCAACACTGAAGCTTTCTTTGGACAA	CANREWGTNTEAFF	In	VDJ	1	47	0.0013460492023942491	0.0017651256243662449	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	7	0	2	9	3	27	34	48	43	51			01,02										Vb 17	CANREWGTNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGAAAGCGGACTGACAATTCACCCCTCCACTTTGGGAAC	CASRKRTDNSPLHF	In	VDJ	1	46	0.0013174098576624568	0.0017275697600180268	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	9	1	10	7	8	3	27	35	48	43	51			01,02			01,02							Vb 17	CASRKRTDNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD02-01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGACAGGGGGGACACTGAAGCTTTCTTTGGACAA	CASSDRGDTEAFF	In	VDJ	1	44	0.0012601311681988716	0.0016524580313215908	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	3	0	1	27	-1	48	39	49			01,02										Vb 17	CASSDRGDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	40	0.0011455737892717014		34	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	5	3	7	1	1	0	27	39	-1	40	42			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACATCCGGGACATACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	40	0.0011455737892717014		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	6	2	5	2	27	44	55	49	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGGCAGGGAGAGAAGATACGCAGTATTTTGGCCCA	CASSIGAGREDTQYF	In	VDJ	1	39	0.001116934444539909	0.001464678709580501	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	4	3	5	5	5	27	41	51	46	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGAGREDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCATTGGGACCGCCAAGAGACCCAGTACTTCGGGCCA	CASSIDHWDRQETQYF	In	VDJ	1	38	0.0010882950998081164	0.001427122845232283	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	0	0	7	1	5	2	27	44	54	49	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDHWDRQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGCCCCGGACACTTATTCACCCCTCCACTTTGGGAAC	CASSIAPDTYSPLHF	In	VDJ	1	37	0.0010596557550763238	0.001389566980884065	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	6	8	6	3	27	41	52	47	55			01,02										Vb 17	CASSIAPDTYSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGACAGGGGGCGCAGATACGCAGTATTTTGGCCCA	CASSIGTGGADTQYF	In	VDJ	1	36	0.0010310164103445314	0.0013520111165358471	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	0	4	1	1	27	41	54	42	55			01,02										Vb 17	CASSIGTGGADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTACGGGGGACTATACGAGCAGTACTTCGGGCCG	CASSYGGLYEQYF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	9	4	5	0	27	39	-1	44	51			01,02			01,02							Vb 17	CASSYGGLYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTTGGACAGGGAAGAAACATTCAGTACTTCGGCGCC	CASSLGQGRNIQYF	In	VDJ	1	28	8.01901652490191E-4	0.0010515642017501032	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	1	3	6	4	3	27	38	50	42	53			01,02										Vb 17	CASSLGQGRNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTGACGGACAGGGGTTAGAAACATTCAGTACTTCGGCGCC	CA*RTGVRNIQYF	Stop	VDJ	1	21	6.014262393676433E-4		39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	11	1	2	6	4	4	27	33	46	37	50			01,02										Vb 17	CA*RTGVRNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGGGGTGTGTCGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	6.014262393676433E-4		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	5	2	3	0	8	27	-1	42	37	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGCCTCCAGGGGGTCCGGTGCAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	5.727868946358507E-4		55	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	1	1	7	9	26	39	53	46	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAATGTCATAGAAGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	19	5.441475499040582E-4		43	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	2	5	4	6	11	0	27	42	-1	53	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAACCCCAGCGGGCAGACACTGAAGCTTTCTTTGGACAA	CASKPQRADTEAFF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	6	4	3	6	3	27	37	49	43	52			01,02			01,02							Vb 17	CASKPQRADTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCAAAAGGACAGCAACTATGGCTACACCTTCGGTTCG	CATQKDSNYGYTF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	1	5	2	7	1	27	34	47	41	48			01,02										Vb 17	CATQKDSNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACAACAGGGGGGGGTCAGCCCCAGCATTTTGGTGAT	CASRTTGGGQPQHF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	1	6	4	3	27	38	50	42	53			01,02										Vb 17	CASRTTGGGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCTTAACGAGGGAGGAGGAAACACCATATATTTTGGAGAG	CASSLNEGGGNTIYF	In	VDJ	1	81	0.0023197869232751953	0.003042025012205656	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	9	1	4	8	1	23	35	49	43	50													Vb 11	CASSLNEGGGNTIYF+TCRBV25-01+TCRBJ01-03	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACTACAGAGAACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	21	6.014262393676433E-4		44	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	5	3	2	4	23	38	44	40	48													Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAACGGGGCAGGAAGATGGCTACACCTTCGGTTCG		Out	VDJ	8	452	0.012944983818770227		44	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	7	0	6	2	6	26	43	50	45	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAATCCACGACTGGGACAGTGGATCCCTACGAGCAGTACTTCGGGCCG	CSAQSTTGTVDPYEQYF	In	VDJ	7	400	0.011455737892717015	0.01502234573928719	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	2	13	6	26	34	54	47	60		TCRBV20-01,TCRBV20-or09_02												CSAQSTTGTVDPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGACAGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	7	358	0.010252885413981729		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	4	1	0	26	35	-1	36	45		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTAAGAGAGGGGGGTATGAAGCTTTCTTTGGACAA	CASSLKRGGYEAFF	In	VDJ	5	278	0.007961737835438324	0.010440530288804597	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	5	1	7	7	3	26	39	52	46	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKRGGYEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCATTGGGACGCGTCTGAGGGATACGCAGTATTTTGGCCCA	CASIGTRLRDTQYF	In	VDJ	4	219	0.006272016496262566	0.008224734292259736	42	unresolved						TCRBJ02	TCRBJ02-03	01	7	0	7	6	2	10	23	33	40	35	50	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIGTRLRDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCAACCCACACAGGCCCCAGCTATGGCTACACCTTCGGTTCG	CASSSTHTGPSYGYTF	In	VDJ	4	207	0.0059283443594810555	0.007774063920081121	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	4	4	9	6	24	36	50	45	56		TCRBV24-01,TCRBV24-or09_02												CASSSTHTGPSYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGCTGTGTATTTCTGTGCCAGCAGCCAAGAGTAGTGCGACAGGGTTTATTGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSQE*CDRVYCSYNSPLHF	Stop	VDJ	3	149	0.004267262365037088		63	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	3	0	7	7	13	30	44	37	51		TCRBV03-01,TCRBV03-02												CASSQE*CDRVYCSYNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCTCGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLSGAGELFF	In	VDJ	3	145	0.004152704986109918	0.005445600330491606	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	8	2	6	3	0	26	39	-1	42	48		TCRBV03-01,TCRBV03-02												CASSLSGAGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGCGGGGGCGTACAAGAGACCCAGTACTTCGGGCCA	CSARSGGVQETQYF	In	VDJ	3	142	0.00406678695191454	0.005332932737446953	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	6	2	2	0	4	26	-1	46	38	50		TCRBV20-01,TCRBV20-or09_02												CSARSGGVQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCTCTTATCCCGGGGGCGTACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	131	0.0037517541598648223		41	unresolved						TCRBJ01	TCRBJ01-01	01	8	6	0	5	9	2	23	32	47	41	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGCCTGCTTCCATTTACACGCACGAAACACCATATATTTTGGAGAG		Out	VDJ	2	129	0.003694475470401237		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	6	5	15	5	26	38	56	53	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGAGGTGGTTCCCATTTACACGCGAAACACCATATATTTTGGAGAG	CASSEVVPIYTRNTIYF	In	VDJ	2	118	0.0033794426783515194	0.004431591993089721	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	11	1	5	0	18	26	-1	42	38	60		TCRBV03-01,TCRBV03-02												CASSEVVPIYTRNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01*02	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTCGAGGGACGCAACGAAAAACTGTTTTTTGGCAGT	CASSVEGRNEKLFF	In	VDJ	2	111	0.0031789672652289716	0.004168700942652195	42	TCRBV03						TCRBJ01	TCRBJ01-04	01	5	0	7	8	5	5	26	38	48	43	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVEGRNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCAGGGCAGGGGGCGTAAGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSPRAGGVRTNEKLFF	In	VDJ	2	109	0.0031216885757653864	0.004093589213955759	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	0	2	6	6	26	39	53	45	59		TCRBV03-01,TCRBV03-02												CASSPRAGGVRTNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGGATGGGGATCGGGTGAGCAGTTCTTCGGGCCA	CASSGWGSGEQFF	In	VDJ	2	106	0.003035770541570009	0.003980921620911106	39	TCRBV24						TCRBJ02	TCRBJ02-01	01	5	0	8	9	4	5	24	37	45	41	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGWGSGEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACTAGCGGGGGGCGACTACAATGAGCAGTTCTTCGGGCCA	CSARGLAGGDYNEQFF	In	VDJ	2	106	0.003035770541570009	0.003980921620911106	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	2	1	3	0	3	26	-1	52	39	55		TCRBV20-01,TCRBV20-or09_02												CSARGLAGGDYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTACGGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLRGANVLTF	In	VDJ	2	98	0.0028066557837156687	0.0036804747061253613	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	8	5	4	0	0	18	-1	-1	33	36	TCRBV07,TCRBV23					01,02								CASSLRGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATACCAGCGGGGGGAATTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	97	0.002778016438983876		49	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	1	1	4	4	26	38	51	42	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGACTAGCGGGGGGGCTTGAAAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	95	0.002720737749520291		52	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	0	0	5	1	8	26	37	54	38	62		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACTACAGGCACAAGAGACCCAGTACTTCGGGCCA	CASSLLQAQETQYF	In	VDJ	2	93	0.002663459060056706	0.0034926953843842715	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	4	2	2	2	26	41	48	43	50		TCRBV12-03,TCRBV12-04												CASSLLQAQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCTGTTCCTACTCTCTARCGGGGGGCAGCACAGATACGCAGTATTTTGGCCCA	CASCSYSLXGGSTDTQYF	In	VDJ	2	91	0.002606180370593121	0.0034175836556878357	54	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	11	8	1	0	18	1	24	31	56	49	57		TCRBV24-01,TCRBV24-or09_02												CASCSYSLXGGSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACAGGGGGAGTGAACGAGCAGTACTTCGGGCCG	CSARDTGGVNEQYF	In	VDJ	2	90	0.0025775410258613283	0.003380027791339618	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	1	5	1	5	26	40	49	41	54		TCRBV20-01,TCRBV20-or09_02												CSARDTGGVNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGTCCGATCGGCTACGAGCAGTACTTCGGGCCG	CSARSPIGYEQYF	In	VDJ	2	88	0.002520262336397743	0.0033049160626431816	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	8	5	3	8	0	26	38	-1	46	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSPIGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACAGAGTGAGCAGTTCTTCGGGCCA	CASSQQSEQFF	In	VDJ	2	85	0.0024343443022023657	0.003192248469598528	33	TCRBV03						TCRBJ02	TCRBJ02-01	01	2	4	5	9	0	2	26	-1	44	41	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQQSEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAACGAGGGGGGCGAATCCTACGAGCAGTACTTCGGGCCG	CSANEGGESYEQYF	In	VDJ	1	81	0.0023197869232751953	0.003042025012205656	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	5	1	1	5	5	26	34	45	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANEGGESYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCAGGGATAATGAGCAGTTCTTCGGGCCA	CASSQVRDNEQFF	In	VDJ	1	81	0.0023197869232751953	0.003042025012205656	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	3	7	1	2	26	42	48	43	50		TCRBV03-01,TCRBV03-02												CASSQVRDNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTAGGACAGGGATGCTTATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	79	0.0022625082338116106		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	0	3	7	26	35	46	38	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCGAGCCATCCATTTGTCATGCAAGATACGCAGTATTTTGGCCCA	CASSSSHPFVMQDTQYF	In	VDJ	1	79	0.0022625082338116106	0.00296691328350922	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	7	5	3	17	26	38	44	41	61		TCRBV03-01,TCRBV03-02				01,02								CASSSSHPFVMQDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACAGACTAGATGGGATACGCAGTATTTTGGCCCA	CASSLQTRWDTQYF	In	VDJ	1	78	0.002233868889079818	0.002929357419161002	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	8	6	2	4	26	41	49	43	53		TCRBV12-03,TCRBV12-04				01,02								CASSLQTRWDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCTGAGCGGTTCACAGATACGCAGTATTTTGGCCCA	CSASPERFTDTQYF	In	VDJ	1	76	0.0021765901996162328	0.002854245690464566	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	6	5	2	5	2	26	37	47	42	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSASPERFTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCTAGCGGGGGTGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	76	0.0021765901996162328		40	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	6	1	2	26	37	48	38	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCTGTTCACAGATACGCAGTATTTTGGCCCA	CASSQGLFTDTQYF	In	VDJ	1	73	0.002090672165420855	0.002741578097419912	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	9	0	2	0	4	26	-1	45	42	49		TCRBV03-01,TCRBV03-02												CASSQGLFTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCTCCGCCAGGGGCGAGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	72	0.002062032820689063		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	4	6	4	19	32	44	38	48	TCRBV07,TCRBV11													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACCCGGGACTAGCGGGGTACGAGCAGTACTTCGGGCCG	CSAYPGLAGYEQYF	In	VDJ	1	72	0.002062032820689063	0.0027040222330716943	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	4	5	0	26	35	-1	40	53		TCRBV20-01,TCRBV20-or09_02												CSAYPGLAGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTAGGGGCCAGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQD*GPGTNTGELFF	Stop	VDJ	1	72	0.002062032820689063		54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	0	8	1	26	43	56	51	57		TCRBV03-01,TCRBV03-02												CASSQD*GPGTNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAATCCCCCGGGCGGACCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	72	0.002062032820689063		40	TCRBV03						TCRBJ02	TCRBJ02-03	01	10	1	7	4	11	1	26	33	48	44	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GRGACWCGGCMCTKTATCTYTGCGCCAGCAGCCAAGAGGCGGGGACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQEAGTGANVLTF	In	VDJ	1	71	0.00203339347595727	0.0026664663687234764	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	2	7	3	2	3	1	20	35	44	38	45	TCRBV05,TCRBV23													CASSQEAGTGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*01	TCRBJ02-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCTCCCGGTAGCCGATACGCAGTATTTTGGCCCA		Out	VDJ	1	71	0.00203339347595727		44	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	7	6	9	1	24	39	52	48	53		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCGGGGGCAAGAGACCCAGTACTTCGGGCCA	CSARRGQETQYF	In	VDJ	1	71	0.00203339347595727	0.0026664663687234764	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	2	2	0	0	26	-1	-1	37	44		TCRBV20-01,TCRBV20-or09_02												CSARRGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGACTAGCGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSPGLAGSTDTQYF	In	VDJ	1	71	0.00203339347595727	0.0026664663687234764	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	0	1	0	26	39	-1	40	53		TCRBV03-01,TCRBV03-02												CASSPGLAGSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAAACTTCRGCGTAGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSLNFXVGSTDTQYF	In	VDJ	1	70	0.0020047541312254776	0.002628910504375258	51	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	2	6	6	0	6	5	18	33	43	39	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02										CASSLNFXVGSTDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTCTCGGGACAGGGCGGGTCACCCCTCCACTTTGGGAAC	CSALSGQGGSPLHF	In	VDJ	1	70	0.0020047541312254776	0.002628910504375258	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	3	10	5	4	26	35	49	40	53		TCRBV20-01,TCRBV20-or09_02												CSALSGQGGSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGGGGGGCTCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAPGGSSSYNEQFF	In	VDJ	1	70	0.0020047541312254776	0.002628910504375258	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	0	2	6	26	34	43	36	49		TCRBV20-01,TCRBV20-or09_02												CSAPGGSSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGAATCCAGGGGGAGGGTGAAAAACTGTTTTTTGGCAGT	CASSRIQGEGEKLFF	In	VDJ	1	69	0.001976114786493685	0.00259135464002704	45	unresolved						TCRBJ01	TCRBJ01-04	01	4	4	1	7	5	4	23	36	48	41	52	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRIQGEGEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCTTGGATCCACAGATACGCAGTATTTTGGCCCA	CSARLGSTDTQYF	In	VDJ	1	69	0.001976114786493685	0.00259135464002704	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	1	8	2	4	2	26	37	44	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARLGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCGTTCCGTATGGTCTTCGGGCCG	CASSQPFRMVF	In	VDJ	1	69	0.001976114786493685	0.00259135464002704	33	TCRBV03						TCRBJ02	TCRBJ02-07	01	2	0	10	15	11	1	26	41	54	52	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPFRMVF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGGGGGGAGGGGACAGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRGEGTDSGANVLTF	In	VDJ	1	69	0.001976114786493685	0.00259135464002704	51	unresolved						TCRBJ02	TCRBJ02-06	01	6	0	5	0	7	1	23	34	48	41	49	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGEGTDSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTGAAGCTAGCGGGGGGGCAGAGACCCAGTACTTCGGGCCA	CASSEASGGAETQYF	In	VDJ	1	68	0.0019474754417618924	0.0025537987756788223	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	4	0	1	23	-1	51	40	52	TCRBV06,TCRBV24													CASSEASGGAETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGTGTTGGGGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CSASVLGGSNQPQHF	In	VDJ	1	66	0.0018901967522983074	0.002478687046982386	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	9	1	0	6	0	26	37	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSASVLGGSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAACAGGGGAATATGAACACTGAAGCTTTCTTTGGACAA	CSAQQGNMNTEAFF	In	VDJ	1	65	0.0018615574075665148	0.0024411311826341682	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	0	2	4	26	35	44	37	48		TCRBV20-01,TCRBV20-or09_02												CSAQQGNMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGTGGCAGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLVAGSYNEQFF	In	VDJ	1	64	0.0018329180628347222	0.0024035753182859504	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	4	0	7	0	24	36	-1	43	47		TCRBV24-01,TCRBV24-or09_02												CASSLVAGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGTCACAGGGACTATAATTCACCCCTCCACTTTGGGAAC	CASSHRDYNSPLHF	In	VDJ	1	64	0.0018329180628347222	0.0024035753182859504	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	3	3	2	1	23	34	42	36	43	TCRBV01,TCRBV04													CASSHRDYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCACGGACAGCTGAGAGCCAAAAACATTCAGTACTTCGGCGCC	CSAHGQLRAKNIQYF	In	VDJ	1	63	0.0018042787181029299	0.0023660194539377325	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	1	5	0	3	5	26	35	44	38	49		TCRBV20-01,TCRBV20-or09_02												CSAHGQLRAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTTAATAGCGGGGGACTAGAGACCCAGTACTTCGGGCCA	CSARDFNSGGLETQYF	In	VDJ	1	63	0.0018042787181029299	0.0023660194539377325	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	2	4	6	3	26	40	55	46	58		TCRBV20-01,TCRBV20-or09_02												CSARDFNSGGLETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACCCCCGAGGTACTGAAGCTTTCTTTGGACAA	CSARDPRGTEAFF	In	VDJ	1	62	0.0017756393733711373	0.0023284635895895146	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	1	7	5	0	9	26	-1	41	37	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPRGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGACTAGCAGAGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	61	0.0017470000286393447		44	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	1	7	4	0	4	24	-1	45	37	49		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGTGGTTTTGTCATGCAAGATACGCAGTATTTTGGCCCA	CASSCGFVMQDTQYF	In	VDJ	1	60	0.0017183606839075523	0.0022533518608930784	45	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	0	10	5	3	12	26	38	43	41	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSCGFVMQDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGTCGGGGACACCCTACGAGCAGTACTTCGGGCCG	CASSQSGTPYEQYF	In	VDJ	1	60	0.0017183606839075523	0.0022533518608930784	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	6	2	4	1	26	40	50	44	51		TCRBV03-01,TCRBV03-02												CASSQSGTPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTACAGTTAACTATGGCTACACCTTCGGTTCG	CASSQGTVNYGYTF	In	VDJ	1	59	0.0016897213391757597	0.0022157959965448605	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	5	1	2	1	26	42	48	44	49		TCRBV03-01,TCRBV03-02												CASSQGTVNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGGACAGGGTGCCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	59	0.0016897213391757597		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	1	3	2	2	3	26	42	52	44	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGACTAGCGGGGGGCGATATTACAATGAGCAGTTCTTCGGGCCA	CASSLATSGGRYYNEQFF	In	VDJ	1	58	0.001661081994443967	0.0021782401321966426	54				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	2	1	4	0	6	18	-1	48	35	54	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLATSGGRYYNEQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACAATCACTAGCGGGGCCCCAGATACGCAGTATTTTGGCCCA	CASTITSGAPDTQYF	In	VDJ	1	58	0.001661081994443967	0.0021782401321966426	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	11	3	3	4	8	3	24	31	49	39	52		TCRBV24-01,TCRBV24-or09_02												CASTITSGAPDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTCATTCGCGGCACAGATACGCAGTATTTTGGCCCA	CASSVIRGTDTQYF	In	VDJ	1	58	0.001661081994443967	0.0021782401321966426	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	7	6	1	7	0	26	38	-1	45	48		TCRBV03-01,TCRBV03-02				01,02								CASSVIRGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGACAGGAGGTGAGGGTTCACCCCTCCACTTTGGGAAC	CASSPTGGEGSPLHF	In	VDJ	1	58	0.001661081994443967	0.0021782401321966426	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	2	4	9	1	9	26	39	46	40	55		TCRBV03-01,TCRBV03-02												CASSPTGGEGSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATCTAGCGAGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	58	0.001661081994443967		41	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	6	3	1	2	26	41	48	42	50		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAAAGATGGATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	55	0.0015751639602485895		40	TCRBV20						TCRBJ01	TCRBJ01-06	01	0	0	10	8	7	0	26	40	-1	47	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCTCAAATTCAAAGTTGGACAGGCGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	54	0.001546524615516797		56	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	4	2	16	2	25	38	61	54	63		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTGGATTGGGGTCCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	54	0.001546524615516797		50							TCRBJ01	TCRBJ01-01	01	0	6	2	0	6	3	18	35	45	41	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01			TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCCCGGAGCAGGGGGCAGGAACATTCAGTACTTCGGCGCC	CSATPGAGGRNIQYF	In	VDJ	1	54	0.001546524615516797	0.0020280166748037707	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	4	0	7	9	3	26	36	53	45	56		TCRBV20-01,TCRBV20-or09_02												CSATPGAGGRNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGACAGGGGACTGGTCCTCACCCCTCCACTTTGGGAAC	CASSQVTGDWSSPLHF	In	VDJ	1	54	0.001546524615516797	0.0020280166748037707	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	2	2	10	1	8	26	42	51	43	59		TCRBV03-01,TCRBV03-02												CASSQVTGDWSSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCCCCGGGGGCAGGGGGATGAGCAGTACTTCGGGCCG		Out	VDJ	1	53	0.0015178852707850045		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	4	1	7	13	2	24	31	51	44	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGACAGGGGTTGCAGAGACCCAGTACTTCGGGCCA	CSAGTGVAETQYF	In	VDJ	1	53	0.0015178852707850045	0.001990460810455553	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	2	4	0	4	26	-1	45	35	49		TCRBV20-01,TCRBV20-or09_02												CSAGTGVAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGGGGGCAATCAGTTACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	53	0.0015178852707850045		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	5	0	3	1	9	26	37	45	38	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACCGATAGCGGGGGGGCTAGAGACCCAGTACTTCGGGCCA	CASSPPIAGGLETQYF	In	VDJ	1	52	0.001489245926053212	0.0019529049461073347	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	5	0	4	6	2	26	39	56	45	58		TCRBV03-01,TCRBV03-02												CASSPPIAGGLETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCTTCTCGGGACAGGGACAAATTGAAGCTTTCTTTGGACAA	XASSFSGQGQIEAFF	In	VDJ	1	52	0.001489245926053212	0.0019529049461073347	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	7	5	6	23	35	49	40	55	TCRBV01,TCRBV07													XASSFSGQGQIEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTGCTTGGGCGGGAGCGCAAGAGACCCAGTACTTCGGGCCA	CASSAWAGAQETQYF	In	VDJ	1	51	0.0014606065813214193	0.0019153490817591166	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	7	2	2	7	2	24	35	49	42	51	TCRBV12,TCRBV21													CASSAWAGAQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGAACCGGGACTAGTCTGACAGATACGCAGTATTTTGGCCCA	CASRTGTSLTDTQYF	In	VDJ	1	51	0.0014606065813214193	0.0019153490817591166	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	8	3	4	4	19	30	42	34	46	TCRBV07,TCRBV11					01,02								CASRTGTSLTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCTCCCGGGGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CSAPLPGVNTGELFF	In	VDJ	1	50	0.001431967236589627	0.0018777932174108987	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	2	1	7	1	26	35	48	42	49		TCRBV20-01,TCRBV20-or09_02												CSAPLPGVNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTCTACTACGAGCAGTACTTCGGGCCG	CSASFYYEQYF	In	VDJ	1	50	0.001431967236589627	0.0018777932174108987	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	9	3	3	0	26	37	-1	40	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSASFYYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGAACAGGGATTAGGCTACACCTTCGGTTCG	CSARVEQGLGYTF	In	VDJ	1	50	0.001431967236589627	0.0018777932174108987	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	3	8	4	4	26	39	49	43	53		TCRBV20-01,TCRBV20-or09_02												CSARVEQGLGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGAGGCGTCGGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSQEEASGPYNEQFF	In	VDJ	1	49	0.0014033278918578343	0.0018402373530626806	51							TCRBJ02	TCRBJ02-01	01	0	7	0	2	9	0	18	35	-1	44	49	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEEASGPYNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCAGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	49	0.0014033278918578343		34	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	5	6	1	0	26	39	-1	40	43		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGCATCTGGAAACACCATATATTTTGGAGAG	CASSQAASGNTIYF	In	VDJ	1	48	0.0013746885471260417	0.0018026814887144628	42	TCRBV03						TCRBJ01	TCRBJ01-03	01	1	9	0	1	1	1	26	42	46	43	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAASGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTCCCCGGACTGGGCCTAGTCCGAAGGGCTTTCTTTGGACAA	CASSLPGLGLVRRAFF	In	VDJ	1	47	0.0013460492023942491	0.0017651256243662449	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	1	10	11	6	16	18	30	41	36	57	TCRBV07,TCRBV11					01,02								CASSLPGLGLVRRAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCTAGGCAGCAGGGGCGGGGAGCTGTTTTTTGGAGAA	CASSLGSRGGELFF	In	VDJ	1	47	0.0013460492023942491	0.0017651256243662449	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	2	7	4	0	18	34	-1	38	44	TCRBV07,TCRBV11													CASSLGSRGGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCGACAGGGGGAGCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	47	0.0013460492023942491		49				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	1	2	6	3	24	36	51	42	54	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												X+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGGGCGAAGAGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	47	0.0013460492023942491		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	8	0	5	0	6	24	-1	46	42	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGATCCCGGGACAGTTGGTTCCATGAACACTGAAGCTTTCTTTGGACAA	CASSQDPGTVGSMNTEAFF	In	VDJ	1	46	0.0013174098576624568	0.0017275697600180268	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	5	0	6	9	20	35	48	41	57	TCRBV01,TCRBV23													CASSQDPGTVGSMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCCCCTAAAGTGGATACGCAGTATTTTGGCCCA	CSARSPKVDTQYF	In	VDJ	1	46	0.0013174098576624568	0.0017275697600180268	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	9	6	5	5	26	37	45	42	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSPKVDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACAAGCGGGGGGGCGGAAGGAGGCGCAGTATTTTGGCCCA	CSAQAGGRKEAQYF	In	VDJ	1	46	0.0013174098576624568	0.0017275697600180268	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	0	10	3	10	26	34	47	37	57		TCRBV20-01,TCRBV20-or09_02												CSAQAGGRKEAQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACGGACAGGGGATATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	46	0.0013174098576624568		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	2	5	3	2	26	42	54	45	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAGGGCCACGCCAGAGCACAGATACGCAGTATTTTGGCCCA	CASSLGPRQSTDTQYF	In	VDJ	1	45	0.0012887705129306642	0.001690013895669809	48	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	1	4	5	0	8	0	18	34	-1	42	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02										CASSLGPRQSTDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTAAACAGGGGTCCTTACGCTGAAGCTTTCTTTGGACAA	CSASLNRGPYAEAFF	In	VDJ	1	45	0.0012887705129306642	0.001690013895669809	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	6	5	8	26	37	49	42	57		TCRBV20-01,TCRBV20-or09_02												CSASLNRGPYAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGTTAGCGGGGGAGAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	45	0.0012887705129306642		44	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	3	5	2	4	4	2	26	37	50	41	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACCGGGACAGGGGGAGAACGGGACTATGGCTACACCTTCGGTTCG	CSARGTGTGGERDYGYTF	In	VDJ	1	45	0.0012887705129306642	0.001690013895669809	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	1	3	5	8	26	39	55	44	63		TCRBV20-01,TCRBV20-or09_02												CSARGTGTGGERDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGGACCTCACCGGGGAGCTGTTTTTTGGAGAA	CSARDLDLTGELFF	In	VDJ	1	45	0.0012887705129306642	0.001690013895669809	42	TCRBV20						TCRBJ02	TCRBJ02-02	01	0	1	7	4	3	2	26	40	47	43	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLDLTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGGAAGGGGCTGGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSRGRGWGNEKLFF	In	VDJ	1	45	0.0012887705129306642	0.001690013895669809	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	2	4	5	6	26	39	49	44	55		TCRBV03-01,TCRBV03-02												CASSRGRGWGNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGAGGGACGGGGTATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	44	0.0012601311681988716		50	TCRBV24						TCRBJ01	TCRBJ01-01	01	0	0	7	0	1	6	24	42	48	43	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGTCAGGGGCTCCCGCCTACGAGCAGTACTTCGGGCCG	CSARSGAPAYEQYF	In	VDJ	1	44	0.0012601311681988716	0.0016524580313215908	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	2	2	5	6	26	34	45	39	51		TCRBV20-01,TCRBV20-or09_02												CSARSGAPAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAGGAAGCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	44	0.0012601311681988716		46	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	1	8	5	2	15	26	38	43	40	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAAGAGGCGGCAGGGACTTCACCCCTCCACTTTGGGAAC	CSAKEAAGTSPLHF	In	VDJ	1	43	0.0012314918234670792	0.001614902166973373	42	TCRBV20						TCRBJ01	TCRBJ01-06	01	6	0	7	9	13	0	26	34	-1	47	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKEAAGTSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCACAGGGGCTTCTATGGCTACACCTTCGGTTCG	CASSQDHRGFYGYTF	In	VDJ	1	43	0.0012314918234670792	0.001614902166973373	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	2	4	2	3	26	43	52	45	55		TCRBV03-01,TCRBV03-02												CASSQDHRGFYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGGGGACTYRGCTKTGTATYTCTGTGCCAGCAGCTTAGCAGGCGGGGGTATCTTGAATGAGCAGTTCTTCGGGCCA	CASSLAGGGILNEQFF	In	VDJ	1	42	0.0012028524787352866	0.0015773463026251548	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	2	7	2	7	22	39	48	41	55	TCRBV07,TCRBV09													CASSLAGGGILNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCATCGGAATTACCGGGACGAGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	42	0.0012028524787352866		49	TCRBV24						TCRBJ02	TCRBJ02-02	01	8	0	7	4	11	4	24	34	50	45	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CRRRGACTYGGSCCTRTATYTCTGTGCCAGCAGCTTGCCAGGGCGGGGACAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSLPGRGQGAYEQYF	In	VDJ	1	42	0.0012028524787352866	0.0015773463026251548	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	1	2	9	0	22	36	-1	45	56	TCRBV04,TCRBV12													CASSLPGRGQGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGGTCGGCGACTATGACTACACCTTCGGTTCG	CSARVGDYDYTF	In	VDJ	1	42	0.0012028524787352866	0.0015773463026251548	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	2	9	10	10	3	26	34	49	44	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVGDYDYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGGGGGCGTGGAGACCCAGTACTTCGGGCCA	CSARGGVETQYF	In	VDJ	1	42	0.0012028524787352866	0.0015773463026251548	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	6	4	1	5	0	6	26	-1	41	34	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGGVETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTTAGTCGGGCCAACTAACTATGGCTACACCTTCGGTTCG	CSASLVGPTNYGYTF	In	VDJ	1	41	0.001174213134003494	0.001539790438276937	45	TCRBV20						TCRBJ01	TCRBJ01-02	01	3	8	0	0	7	3	26	37	48	44	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASLVGPTNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTCGGGACAGGGGATTATGGCTACACCTTCGGTTCG	CSARDLGTGDYGYTF	In	VDJ	1	41	0.001174213134003494	0.001539790438276937	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	2	5	4	2	26	40	54	44	56		TCRBV20-01,TCRBV20-or09_02												CSARDLGTGDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATCCTCCGGGACAGAAAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	41	0.001174213134003494		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	5	7	6	2	26	40	53	46	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTACTCCCGGCGGTACGCAGTATTTTGGCCCA	CASSQVTPGGTQYF	In	VDJ	1	41	0.001174213134003494	0.001539790438276937	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	7	5	8	9	0	26	42	-1	51	55		TCRBV03-01,TCRBV03-02				01,02								CASSQVTPGGTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCGGGACTAGTCGAGACCCAGTACTTCGGGCCA	CASSQDPGLVETQYF	In	VDJ	1	41	0.001174213134003494	0.001539790438276937	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	8	5	3	2	26	43	54	46	56		TCRBV03-01,TCRBV03-02				01,02								CASSQDPGLVETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCCCGGGACTAGCGGGTACAATGAGCAGTTCTTCGGGCCA	CSASPGTSGYNEQFF	In	VDJ	1	40	0.0011455737892717014	0.0015022345739287189	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	4	4	6	0	26	35	-1	41	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSASPGTSGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTAAGGGGGACCCAAGAGACCCAGTACTTCGGGCCA	CSAVRGTQETQYF	In	VDJ	1	40	0.0011455737892717014	0.0015022345739287189	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	5	1	1	3	2	26	35	44	38	46		TCRBV20-01,TCRBV20-or09_02												CSAVRGTQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCAGGGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	40	0.0011455737892717014		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	1	4	1	0	26	37	-1	38	45		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCACGGACTAGCGGGGGGAGCGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	40	0.0011455737892717014		52	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	1	1	3	5	4	26	38	57	43	61		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGGGGCAGAAAGTCAGCCCCAGCATTTTGGTGAT	CSARGGAESQPQHF	In	VDJ	1	40	0.0011455737892717014	0.0015022345739287189	42	TCRBV20						TCRBJ01	TCRBJ01-05	01	1	6	0	6	1	6	26	39	46	40	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGGAESQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGGACCCCCTGGGGAGGTCACCCCTCCACTTTGGGAAC	CASSPDPLGRSPLHF	In	VDJ	1	40	0.0011455737892717014	0.0015022345739287189	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	9	1	10	12	0	26	38	-1	50	56		TCRBV12-03,TCRBV12-04												CASSPDPLGRSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD02-01*02	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTAGGAAATTCGAACAATGAGCAGTTCTTCGGGCCA	CASSLGNSNNEQFF	In	VDJ	1	39	0.001116934444539909	0.001464678709580501	42	unresolved						TCRBJ02	TCRBJ02-01	01	2	1	8	5	1	7	19	33	37	34	44	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGNSNNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCGCCCCCCGTGGGGGGGGCGGCTACACCTTCGGTTCG	CATSAPRGGGGYTF	In	VDJ	1	39	0.001116934444539909	0.001464678709580501	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	9	0	8	10	2	24	35	52	45	54		TCRBV24-01,TCRBV24-or09_02												CATSAPRGGGGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTTAGCGGGGGCCGTGCGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	39	0.001116934444539909		47	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	5	2	0	2	7	26	36	47	38	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGCCACTGAAGCTTTCTTTGGACAA	CASSQVATEAFF	In	VDJ	1	39	0.001116934444539909	0.001464678709580501	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	9	0	4	1	0	26	42	-1	43	46		TCRBV03-01,TCRBV03-02												CASSQVATEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTAGGTTTACGATATCCCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	38	0.0010882950998081164		53	unresolved						TCRBJ02	TCRBJ02-04	01	1	2	8	0	6	7	18	34	42	40	49	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGCATGCGGTACTATGGCTACACCTTCGGTTCG	CASSQGMRYYGYTF	In	VDJ	1	38	0.0010882950998081164	0.001427122845232283	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	7	5	3	4	1	23	39	47	43	48	TCRBV01,TCRBV04					01,02								CASSQGMRYYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAATTCGGCAGGCATTCCTACGAGCAGTACTTCGGGCCG	CASSQEFGRHSYEQYF	In	VDJ	1	38	0.0010882950998081164	0.001427122845232283	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	4	1	6	3	23	40	50	46	53	TCRBV01,TCRBV04													CASSQEFGRHSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCAACCCTAGCGTTCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARATLAFSYNEQFF	In	VDJ	1	38	0.0010882950998081164	0.001427122845232283	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	6	0	7	2	26	37	50	44	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARATLAFSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGGGCTGGGACACAGAACACTGAAGCTTTCTTTGGACAA	CSARRAGTQNTEAFF	In	VDJ	1	38	0.0010882950998081164	0.001427122845232283	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	1	6	2	26	38	50	44	52		TCRBV20-01,TCRBV20-or09_02												CSARRAGTQNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCAGGTGGGAGACCCAGTACTTCGGGCCA	CASSPRWETQYF	In	VDJ	1	38	0.0010882950998081164	0.001427122845232283	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	4	5	1	3	26	39	44	40	47		TCRBV03-01,TCRBV03-02												CASSPRWETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTAATATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	38	0.0010882950998081164		37	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	9	4	0	3	26	-1	42	40	45		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACAATCCCCGGCGGACACTGAAGCTTTCTTTGGACAA	CASSLQSPADTEAFF	In	VDJ	1	37	0.0010596557550763238	0.001389566980884065	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	7	5	3	12	0	24	36	-1	48	52		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLQSPADTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATACAGGGAGCACAGATACGCAGTATTTTGGCCCA	CATSDTGSTDTQYF	In	VDJ	1	37	0.0010596557550763238	0.001389566980884065	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	3	0	0	0	24	-1	-1	39	45		TCRBV24-01,TCRBV24-or09_02												CATSDTGSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCCAGCGATCACACAGATACGCAGTATTTTGGCCCA	CSARASDHTDTQYF	In	VDJ	1	37	0.0010596557550763238	0.001389566980884065	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	6	6	2	4	4	26	37	45	41	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARASDHTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATTTACAGGGAAAGCTAAATGAAAAACTGTTTTTTGGCAGT	CASSHLQGKLNEKLFF	In	VDJ	1	37	0.0010596557550763238	0.001389566980884065	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	3	5	3	7	26	40	49	43	56		TCRBV03-01,TCRBV03-02												CASSHLQGKLNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGTGCTGGCGGGGAGTCAAGAGACCCAGTACTTCGGGCCA	CASSQDVLAGSQETQYF	In	VDJ	1	37	0.0010596557550763238	0.001389566980884065	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	7	3	2	7	3	26	43	56	50	59		TCRBV03-01,TCRBV03-02												CASSQDVLAGSQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTCCCCGGGGCCTAGCGGGCGTCCTGTACTTCGGGCCA		Out	VDJ	1	36	0.0010310164103445314		43	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	4	4	13	9	6	18	31	48	40	54	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCGAGGGGCCTGAGCAGTTCTTCGGGCCA	CSAIEGPEQFF	In	VDJ	1	36	0.0010310164103445314	0.0013520111165358471	33	TCRBV20						TCRBJ02	TCRBJ02-01	01	4	5	2	9	3	2	26	36	44	39	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAIEGPEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCAGGGGAAGGGAGCAGTACTTCGGGCCG	CSARDPRGREQYF	In	VDJ	1	36	0.0010310164103445314	0.0013520111165358471	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	7	3	4	26	40	49	43	53		TCRBV20-01,TCRBV20-or09_02												CSARDPRGREQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTCCAACTGACGGACTCAGGTTACGAGCAGTACTTCGGGCCG	CASSFQLTDSGYEQYF	In	VDJ	1	36	0.0010310164103445314	0.0013520111165358471	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	10	4	11	5	26	38	54	49	59		TCRBV03-01,TCRBV03-02				01,02								CASSFQLTDSGYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATAATCCTAAAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSHNPKSSYEQYF	In	VDJ	1	36	0.0010310164103445314	0.0013520111165358471	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	9	0	5	4	26	40	48	45	52		TCRBV03-01,TCRBV03-02				01,02								CASSHNPKSSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGAGGGGACCCGCTGAATACGCAGTATTTTGGCCCA	CSARDGGDPLNTQYF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	0	7	1	10	26	40	47	41	57		TCRBV20-01,TCRBV20-or09_02												CSARDGGDPLNTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATGAGGGGGGGGAATCAGCCCCAGCATTTTGGTGAT	CSARDMRGGNQPQHF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	9	0	4	5	1	26	40	52	45	53		TCRBV20-01,TCRBV20-or09_02												CSARDMRGGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAAGGAACACTGAAGCTTTCTTTGGACAA	CSARERNTEAFF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	5	5	1	1	0	26	40	-1	41	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARERNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGATTGGTCGGACAGGGACAGAGACCCAGTACTTCGGGCCA	CASSQIGRTGTETQYF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	3	4	8	2	23	37	53	45	55	TCRBV01,TCRBV04													CASSQIGRTGTETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATTGGGCAGCTGGGGCCAACGTCCTGACTTTCGGGGCC	XASSQDWAAGANVLTF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	8	0	2	2	2	23	40	46	42	48	TCRBV01,TCRBV04													XASSQDWAAGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCATACTAGCGCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSILAPSYNEQFF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	6	0	3	2	26	37	47	40	49		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSILAPSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCTATCCGATACGCAGTATTTTGGCCCA	CSARLSDTQYF	In	VDJ	1	34	9.737377208809462E-4	0.0012768993878394112	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	9	6	1	3	26	37	41	38	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSARLSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCATCAGGGTTGGTTCAATGAGCAGTTCTTCGGGCCA	CSARDHQGWFNEQFF	In	VDJ	1	34	9.737377208809462E-4	0.0012768993878394112	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	6	4	6	26	40	49	44	55		TCRBV20-01,TCRBV20-or09_02												CSARDHQGWFNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTGGGTTGGAAGGCACAGATACGCAGTATTTTGGCCCA	CASSPGLEGTDTQYF	In	VDJ	1	34	9.737377208809462E-4	0.0012768993878394112	45	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	0	9	1	2	7	26	39	44	41	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGLEGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATACCTAGCGGGGTTTATTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	34	9.737377208809462E-4		50	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	4	3	6	26	43	55	46	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCCCGAAGGGGGCGAAGGGTGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	34	9.737377208809462E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	5	0	4	4	8	24	30	41	34	49	TCRBV06,TCRBV10													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCCGGGACAGGATTACAATGAGCAGTTCTTCGGGCCA	CASSPGQDYNEQFF	In	VDJ	1	34	9.737377208809462E-4	0.0012768993878394112	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	4	2	2	24	36	46	38	48	TCRBV06,TCRBV10													CASSPGQDYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGAGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGGSSYNEQFF	In	VDJ	1	33	9.450983761491537E-4	0.001239343523491193	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	2	0	2	0	23	39	-1	41	46	TCRBV09,TCRBV21													CASSVGGSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCCAGAAGGGAACCTACGAGCAGTACTTCGGGCCG	CSARDPQKGTYEQYF	In	VDJ	1	33	9.450983761491537E-4	0.001239343523491193	45	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	0	8	2	9	1	26	40	53	49	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPQKGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCCTTACAGGGGAAAGCGGGGAGCTGTTTTTTGGAGAA	CASSLTGESGELFF	In	VDJ	1	32	9.164590314173611E-4	0.0012017876591429752	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	2	7	4	4	23	34	45	38	49	TCRBV06,TCRBV10													CASSLTGESGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGGATGGTGGGTGGAGAGGGGGCGTTCGGTGAGACCCAGTACTTCGGGCCA	CASGMVGGEGAFGETQYF	In	VDJ	1	32	9.164590314173611E-4	0.0012017876591429752	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	11	5	0	5	18	7	24	31	56	49	63		TCRBV24-01,TCRBV24-or09_02												CASGMVGGEGAFGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTAATGCAGGGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	32	9.164590314173611E-4		47	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	3	0	5	0	26	40	-1	45	50		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAAGGGGACAGGGTACACAGATACGCAGTATTTTGGCCCA	CASSLKGTGYTDTQYF	In	VDJ	1	32	9.164590314173611E-4	0.0012017876591429752	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	3	2	3	2	26	41	53	44	55		TCRBV12-03,TCRBV12-04												CASSLKGTGYTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGGTCAGGGGATCGCCCGCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	31	8.878196866855686E-4		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	4	2	7	4	8	24	33	43	37	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGTGGACAGGGTGATACTTCACCCCTCCACTTTGGGAAC	CSASSGQGDTSPLHF	In	VDJ	1	31	8.878196866855686E-4	0.0011642317947947573	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	3	9	4	6	26	37	49	41	55		TCRBV20-01,TCRBV20-or09_02												CSASSGQGDTSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACCACAGGGAAGGCGGCTACACCTTCGGTTCG		Out	VDJ	1	31	8.878196866855686E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	3	8	3	5	26	38	47	41	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTGGACAGGGAAGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	8.591803419537761E-4		46				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	3	7	1	5	18	35	44	36	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCGCTAGCGGGGGGCGGTGATACGCAGTATTTTGGCCCA	CASSESLAGGGDTQYF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	48	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	6	3	4	23	38	52	41	56		TCRBV06-01,TCRBV06-08												CASSESLAGGGDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTATCGCCCCGGGGACTGAAGCTTTCTTTGGACAA	CASSIAPGTEAFF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	3	5	7	0	24	36	-1	43	48		TCRBV24-01,TCRBV24-or09_02												CASSIAPGTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGGGGCCGGCACAGATACGCAGTATTTTGGCCCA	CSASGGAGTDTQYF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	0	1	0	3	26	-1	45	37	48		TCRBV20-01,TCRBV20-or09_02												CSASGGAGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGCCCGTTACAAATAATGGCTACACCTTCGGTTCG	CSARVPVTNNGYTF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	6	6	8	4	26	39	50	47	54		TCRBV20-01,TCRBV20-or09_02												CSARVPVTNNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGGTCGGGAACACTGAAGCTTTCTTTGGACAA	CSARDWVGNTEAFF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	0	9	1	2	4	26	40	45	42	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDWVGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGGGAGGAAGTCGCCCTGGCTACACCTTCGGTTCG	CASRGGSRPGYTF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	1	7	0	9	26	-1	43	37	52		TCRBV03-01,TCRBV03-02												CASRGGSRPGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAACCCTAGGCAGGGGGCTGGAAGGCTACACCTTCGGTTCG	CASSQETLGRGLEGYTF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	0	8	9	5	26	43	60	52	65		TCRBV03-01,TCRBV03-02												CASSQETLGRGLEGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGGCAAGCGGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	30	8.591803419537761E-4		50	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	6	1	1	3	0	23	39	-1	42	51	TCRBV01,TCRBV04													X+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGTCCGTGGAGGCAGCAAGAGACCCAGTACTTCGGGCCA	CASGPWRQQETQYF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	11	10	1	2	9	3	24	31	45	40	48		TCRBV24-01,TCRBV24-or09_02												CASGPWRQQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGTAACCTACGAGCAGTACTTCGGGCCG	CATSDVTYEQYF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	9	2	2	1	24	38	42	40	43		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDVTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGGGACAGTGAAGTCGGGCACTGAAGCTTTCTTTGGACAA	CSAGGTVKSGTEAFF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	4	3	10	26	35	45	38	55		TCRBV20-01,TCRBV20-or09_02												CSAGGTVKSGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGACAGGGTCGGAGACGAGCAGTACTTCGGGCCG	CSASDRVGDEQYF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	3	5	1	6	26	37	45	38	51		TCRBV20-01,TCRBV20-or09_02												CSASDRVGDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTCGGTCGGACAATGAGCAGTTCTTCGGGCCA	CSARGRSDNEQFF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	8	5	5	2	4	26	39	44	41	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGRSDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCTAAGGACAGTAGCAATCAGCCCCAGCATTTTGGTGAT	CSARDPKDSSNQPQHF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	5	0	6	0	26	40	-1	46	52		TCRBV20-01,TCRBV20-or09_02												CSARDPKDSSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTCGCTGAAGCTTTCTTTGGACAA	CASSQFAEAFF	In	VDJ	1	28	8.01901652490191E-4	0.0010515642017501032	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	8	6	6	2	0	26	41	-1	43	45		TCRBV03-01,TCRBV03-02				01,02								CASSQFAEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATTAGACTCCCATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	8.01901652490191E-4		43	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	2	10	3	3	5	26	41	48	44	53		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTCGGGCCGCCCGAACTACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	28	8.01901652490191E-4		46	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	8	0	3	3	10	26	38	45	41	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCGGGCAGGGTTTAACCTACGAGCAGTACTTCGGGCCG	CAGQGLTYEQYF	In	VDJ	1	27	7.732623077583984E-4	0.0010140083374018853	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	4	3	2	3	5	23	29	37	32	42	TCRBV02,TCRBV12													CAGQGLTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGACGACAGCCAAGAGACCCAGTACTTCGGGCCA	CASSDDSQETQYF	In	VDJ	1	27	7.732623077583984E-4	0.0010140083374018853	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	5	1	1	0	23	37	-1	38	43	TCRBV02,TCRBV21													CASSDDSQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCACTTAGTGGGGACAGCTAAAGGTGGGGAGCTGTTTTTTGGAGAA	CASSHLVGTAKGGELFF	In	VDJ	1	27	7.732623077583984E-4	0.0010140083374018853	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	5	8	10	8	24	35	52	45	60		TCRBV24-01,TCRBV24-or09_02												CASSHLVGTAKGGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGGATCGACGAGAGCAGGAAAGACCTATGGCTACACCTTCGGTTCG	CASSGSTRAGKTYGYTF	In	VDJ	1	27	7.732623077583984E-4	0.0010140083374018853	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	4	4	13	6	22	34	51	47	57		TCRBV12-03,TCRBV12-04												CASSGSTRAGKTYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACATCGGGACCCACCGTCCTGAAGCTTTCTTTGGACAA	CSADIGTHRPEAFF	In	VDJ	1	27	7.732623077583984E-4	0.0010140083374018853	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	0	7	6	6	8	26	35	46	41	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSADIGTHRPEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACAGGGACACTGAAGCTTTCTTTGGACAA	CSARDRDTEAFF	In	VDJ	1	27	7.732623077583984E-4	0.0010140083374018853	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	3	3	0	0	26	-1	-1	37	45		TCRBV20-01,TCRBV20-or09_02												CSARDRDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGACGTAGCGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASRRSGGYNEQFF	In	VDJ	1	27	7.732623077583984E-4	0.0010140083374018853	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	5	1	4	3	0	24	35	-1	38	48	TCRBV06,TCRBV10													CASRRSGGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACTAGCGGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSLLAGSTDTQYF	In	VDJ	1	27	7.732623077583984E-4	0.0010140083374018853	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	4	0	0	1	26	-1	49	41	50		TCRBV12-03,TCRBV12-04				01,02								CASSLLAGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCAACTAGCGGGGGGGCGGATACGCAGTATTTTGGCCCA	CASSSTSGGADTQYF	In	VDJ	1	26	7.44622963026606E-4	9.764524730536674E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	3	0	6	2	2	18	31	46	33	48	TCRBV07,TCRBV11													CASSSTSGGADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCGGGACTAGCGGGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGLAGDTGELFF	In	VDJ	1	26	7.44622963026606E-4	9.764524730536674E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	0	2	3	2	0	18	30	-1	32	46	TCRBV07,TCRBV11													CASSPGLAGDTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACTTTTCTCCGGGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTFLRGSSYNEQFF	In	VDJ	1	26	7.44622963026606E-4	9.764524730536674E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	8	3	0	8	3	23	33	46	41	49	TCRBV06,TCRBV10													CASTFLRGSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGCTTCTACATCTGCAGTGCTAGAGAACACCGGGACAGGGGGATTATTTTCTTTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	7.44622963026606E-4		61	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	1	1	5	12	13	27	43	32	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGARGACTCRGCCCTKTATCTYTGCGCCAGCAGCCGACTAGCGGGAGACTACAATGAGCAGTTCTTCGGGCCA	CASSRLAGDYNEQFF	In	VDJ	1	26	7.44622963026606E-4	9.764524730536674E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	2	2	3	0	1	23	-1	48	36	49	TCRBV04,TCRBV05													CASSRLAGDYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGAACAGGGATCCACGAGCAGTACTTTGGGCCG	CSARDGTGIHEQYF	In	VDJ	1	26	7.44622963026606E-4	9.764524730536674E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	3	19	4	18	26	40	50	44	68		TCRBV20-01,TCRBV20-or09_02												CSARDGTGIHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCACGCGACAGTCCGACGAAGCTTTCTTTGGACAA	CSATTRQSDEAFF	In	VDJ	1	26	7.44622963026606E-4	9.764524730536674E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	8	6	6	26	36	47	42	53		TCRBV20-01,TCRBV20-or09_02												CSATTRQSDEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGAAGTTCTAGCGGGGGGGTGCATGAGCAGTTCTTCGGGCCA	CASSGSSSGGVHEQFF	In	VDJ	1	26	7.44622963026606E-4	9.764524730536674E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	8	7	3	26	38	57	45	60		TCRBV03-01,TCRBV03-02												CASSGSSSGGVHEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTGTTGGCTAGCGGGGTAACCGGGGAGCTGTTTTTTGGAGAA	CASSLLASGVTGELFF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	4	3	5	7	2	24	36	52	43	54	TCRBV24,TCRBV27													CASSLLASGVTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGAGGTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	25	7.159836182948135E-4		41	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	11	1	4	4	0	24	36	-1	40	44		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01*02	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGCCTCGGGCAGCAACACTGAAGCTTTCTTTGGACAA	CASRASGSNTEAFF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	42	TCRBV24						TCRBJ01	TCRBJ01-01	01	7	8	0	2	6	3	24	35	45	41	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRASGSNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCAAGGGGAAGCCAAGAGACCCAGTACTTCGGGCCA	CASSQARGSQETQYF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	5	2	1	2	3	23	39	46	41	49	TCRBV01,TCRBV04													CASSQARGSQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGCAGGGGGATAATTCACCCCTCCACTTTGGGAAC	CSARDLQGDNSPLHF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	1	5	4	0	26	40	-1	44	51		TCRBV20-01,TCRBV20-or09_02												CSARDLQGDNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGAGGGAGGGGCAGTAATTCACCCCTCCACTTTGGGAAC	CASSLGGRGSNSPLHF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	9	0	6	2	4	26	42	51	44	55		TCRBV12-03,TCRBV12-04												CASSLGGRGSNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD02-01*02	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTGCCAGATGTGAACACTGAAGCTTTCTTTGGACAA	CASSLPDVNTEAFF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	5	0	1	3	19	34	38	35	41	TCRBV05,TCRBV07													CASSLPDVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTAACACAGGGGGCTGCTTGGCTACACCTTCGGTTCG	CASS*HRGLLGYTF	Stop	VDJ	1	24	6.873442735630209E-4		42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	0	7	3	4	19	32	44	35	48	TCRBV05,TCRBV11													CASS*HRGLLGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCAGACACGCGGGGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQTRGGSSYEQYF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	48	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	7	1	0	7	2	19	31	46	38	48		TCRBV05-06,TCRBV05-07												CASSQTRGGSSYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGATGGGGTATCCTACGAGCAGTACTTCGGGCCG	CASSLDGVSYEQYF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	2	6	2	1	4	2	19	33	41	37	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGVSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATAATGGACTAGTGTTCAAGAGACCCAGTACTTCGGGCCA	CASSL*WTSVQETQYF	Stop	VDJ	1	24	6.873442735630209E-4		48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	8	2	7	4	24	36	50	43	54		TCRBV24-01,TCRBV24-or09_02				01,02								CASSL*WTSVQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGTCATAGCGGGGAACGCACAGATACGCAGTATTTTGGCCCA	CASSHSGERTDTQYF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	3	1	2	3	24	36	46	38	49	TCRBV24,TCRBV28													CASSHSGERTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCAGACAGAGGCATTCAGTACTTCGGCGCC	CSARADRGIQYF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	2	5	9	2	3	26	39	46	41	49		TCRBV20-01,TCRBV20-or09_02												CSARADRGIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGACTCTAGCAATCACAGATACGCAGTATTTTGGCCCA	CSARDRTLAITDTQYF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	1	10	2	2	8	26	40	47	42	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRTLAITDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTCACGGACACCGAGCAGTACTTCGGGCCG	CSARLTDTEQYF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	6	6	5	1	26	38	48	43	49		TCRBV20-01,TCRBV20-or09_02												CSARLTDTEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTACCCCTCCGGACAGGGTGTTCGAGCAGTACTTCGGGCCG	CAISTPPDRVFEQYF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	6	8	4	23	35	51	43	55	TCRBV06,TCRBV10													CAISTPPDRVFEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTACGGACAGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTDSSNQPQHF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	5	0	2	0	23	35	-1	37	43	TCRBV06,TCRBV10													CASSTDSSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCACGTCACAGGGGGCCGCTATGAACACTGAAGCTTTCTTTGGACAA	CSAPTSQGAAMNTEAFF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	0	0	8	5	26	35	52	43	57		TCRBV20-01,TCRBV20-or09_02												CSAPTSQGAAMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGGGGACTAGCCAATACGAGCAGTACTTCGGGCCG	CSARDWGTSQYEQYF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	7	4	4	3	26	40	53	44	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDWGTSQYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCAGGGGGCTATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	23	6.587049288312284E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	0	8	3	1	26	40	51	43	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAATTGCGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CSARELRGGTGELFF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	7	3	4	3	3	26	40	49	43	52		TCRBV20-01,TCRBV20-or09_02												CSARELRGGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTCCCGGCCGGGGCCACCTACGGCTACACCTTCGGTTCG	CSALPAGATYGYTF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	7	0	8	10	7	26	34	49	44	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALPAGATYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTCCTCTGGGGACAACGTGAAGAGACCCAGTACTTCGGGCCA	CASSFLWGQREETQYF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	6	3	6	5	19	33	45	39	50	TCRBV05,TCRBV07													CASSFLWGQREETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGCGGGGCCCCTTTATAGGGGCTTTCTTTGGACAA	CSARDGRGPFIGAFF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	7	3	11	3	13	26	40	49	43	62		TCRBV20-01,TCRBV20-or09_02												CSARDGRGPFIGAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCCGGGACGAGGGACACTGAAGCTTTCTTTGGACAA	CSASGTRDTEAFF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	0	7	3	4	5	26	34	43	38	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGTRDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGAGGGGGCGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGRGRNTGELFF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	5	0	1	2	1	26	42	51	44	52		TCRBV03-01,TCRBV03-02												CASSQGRGRNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CARSGACTYGGSCCTRTATYTCTGTGCCAGCAGCTCCGGGACTGAGGAGAGAGTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	6.300655840994358E-4		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	0	10	5	2	11	20	33	41	35	52	TCRBV05,TCRBV12					01,02								X+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGGAAACGGGAGGTCTGAGACCCAGTACTTCGGGCCA	CASSVGNGRSETQYF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	8	1	5	9	3	26	37	53	46	56	TCRBV09,TCRBV12													CASSVGNGRSETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCCGGGACTAGGGGATCGGCCGGGGAGCTGTTTTTTGGAGAA	CASSPGTRGSAGELFF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	8	6	4	8	26	37	49	41	57	TCRBV09,TCRBV12					01,02								CASSPGTRGSAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCACCCACCCGGCCCAGGGGGCTTTGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	21	6.014262393676433E-4		53	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	0	5	13	5	24	36	57	49	62		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATAGGGGACAGGGGACTGAAGCTTTCTTTGGACAA	CASSQDRGQGTEAFF	In	VDJ	1	21	6.014262393676433E-4	7.886731513125774E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	2	5	3	0	23	40	-1	43	53	TCRBV01,TCRBV04													CASSQDRGQGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTTCGTATCGGGGCCAAGAGACCCAGTACTTCGGGCCA	CSVSYRGQETQYF	In	VDJ	1	21	6.014262393676433E-4	7.886731513125774E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	8	3	1	8	0	26	33	-1	41	46		TCRBV20-01,TCRBV20-or09_02												CSVSYRGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCAACCGGGACAGCCGATAATTCACCCCTCCACTTTGGGAAC	CSAATGTADNSPLHF	In	VDJ	1	21	6.014262393676433E-4	7.886731513125774E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	5	5	6	3	26	35	48	41	51		TCRBV20-01,TCRBV20-or09_02												CSAATGTADNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAATCGTGGCGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLIVAGSYEQYF	In	VDJ	1	21	6.014262393676433E-4	7.886731513125774E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	7	4	0	6	0	26	41	-1	47	52		TCRBV12-03,TCRBV12-04				01,02								CASSLIVAGSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCCATCTAGCGGGGGAACGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	21	6.014262393676433E-4		52	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	4	2	0	6	2	26	37	53	43	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAATCGGGGTACTCCTACGAGCAGTACTTCGGGCCG	CASSVESGYSYEQYF	In	VDJ	1	20	5.727868946358507E-4	7.511172869643594E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	0	3	2	23	39	47	42	49	TCRBV09,TCRBV21													CASSVESGYSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTTGGGTCGCGCACAGGAGACTATGGCTACACCTTCGGTTCG	CASSFGSRTGDYGYTF	In	VDJ	1	20	5.727868946358507E-4	7.511172869643594E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	4	3	10	2	19	33	48	43	50	TCRBV05,TCRBV11													CASSFGSRTGDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCCACCGGGGGGCCGACTACAATGAGCAGTTCTTCGGGCCA	CASSHRGADYNEQFF	In	VDJ	1	20	5.727868946358507E-4	7.511172869643594E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	1	3	3	4	19	31	41	34	45	TCRBV05,TCRBV07													CASSHRGADYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCACCGTATCCCCCCTGCAGCGGGGGGCGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	5.727868946358507E-4		53	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	1	7	15	4	19	29	53	44	57		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCGCGTGGGGAGTCGGAGACCCAGTACTTCGGGCCA	CSAPRGESETQYF	In	VDJ	1	20	5.727868946358507E-4	7.511172869643594E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	2	5	8	3	26	34	47	42	50		TCRBV20-01,TCRBV20-or09_02												CSAPRGESETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCGCCAAAAAAAAGGGGACAGAACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	5.727868946358507E-4		44	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	0	5	2	12	2	26	32	51	44	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGGACAAACAACTTTAAAAAACTACGCAGTATTTTGGCCCA		Out	VDJ	1	20	5.727868946358507E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	6	8	0	16	24	-1	39	35	55	TCRBV06,TCRBV10													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTTTTAGGACACCGACGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	5.727868946358507E-4		49	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	6	0	5	6	26	40	50	45	56		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGGACTCSGCCRTGTATCTCTGTGCAAGTCGCTCGGACAGGTGGAGCTCTGGAAACACCATATATTTTGGAGAG	CASRSDRWSSGNTIYF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	1	4	0	1	5	19	32	40	33	45	TCRBV07,TCRBV12													CASRSDRWSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGGGCGACGGGGGGCGTCCCCTACGAGCAGTACTTCGGGCCG	CASRATGGVPYEQYF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	1	2	5	5	18	29	41	34	46	TCRBV11,TCRBV23													CASRATGGVPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAATCATATCACAGGGTAAAAATCAGCCCCAGCATTTTGGTGAT	CASSLIISQGKNQPQHF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	4	8	4	18	33	47	41	51	TCRBV07,TCRBV11													CASSLIISQGKNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCACATTCCCCGACGGACAGCCGCCCCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	19	5.441475499040582E-4		56	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	5	5	13	7	18	31	50	44	57	TCRBV07,TCRBV11													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GMGACWCGGCWSTGTATCTCTGYGCCAGCAGCTTCGCGGGGGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSFAGGSYNEQFF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	7	1	1	1	1	19	33	42	34	43	TCRBV07,TCRBV23													CASSFAGGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGTAGTTTAACAGCCGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLTAGSSYNEQFF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	3	5	0	8	7	24	31	43	39	50	TCRBV24,TCRBV27													CASSLTAGSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTATCAATTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSINYSNQPQHF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	42	TCRBV24						TCRBJ01	TCRBJ01-05	01	6	4	6	0	2	4	24	36	40	38	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSINYSNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCCCTCCGAGCGGGGGGGCAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	19	5.441475499040582E-4		44	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	6	0	5	6	2	22	31	47	37	49	TCRBV09,TCRBV12													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTTGCCCGGACTAGCGGTTCGCTCCCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	19	5.441475499040582E-4		56	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	1	5	4	6	8	23	36	52	42	60	TCRBV01,TCRBV04					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGGACTAGCGGGGGGGCATGTGGATGAGCAGTTCTTCGGGCCA	CASSQGLAGGHVDEQFF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	2	0	8	0	7	23	-1	53	39	60	TCRBV04,TCRBV23													CASSQGLAGGHVDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTACCTAGCGGGGGACCAAGAGACCCAGTACTTCGGGCCA	CSARDYLAGDQETQYF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	2	0	4	0	26	40	-1	44	54		TCRBV20-01,TCRBV20-or09_02												CSARDYLAGDQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACGCCCCCACGACAGGGTCCGGGAGACCCAGTACTTCGGGCCA	CSARPHDRVRETQYF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	5	10	5	26	34	51	44	56		TCRBV20-01,TCRBV20-or09_02												CSARPHDRVRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATCGACAGGGTCTGAAGCTTTCTTTGGACAA	CASSQSTGSEAFF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	3	6	2	1	26	41	50	43	51		TCRBV03-01,TCRBV03-02												CASSQSTGSEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCCGGGACCCGCGCAACGAGCAGTACTTCGGGCCG	CASSQGRDPRNEQYF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	45	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	0	7	5	3	7	26	42	50	45	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGRDPRNEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTGGCGGCAGGGACCTACGAGCAGTACTTCGGGCCG	CASSLAAGTYEQYF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	2	3	1	19	35	43	38	44	TCRBV05,TCRBV11													CASSLAAGTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTGTGTTAGGGGGGACCAAAAACATTCAGTACTTCGGCGCC	CASSLAVLGGTKNIQYF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	51							TCRBJ02	TCRBJ02-04	01	0	5	1	2	6	2	18	35	47	41	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAVLGGTKNIQYF+X+TCRBJ02-04			TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGTTAGGGGATCCGGGGACCAGTACTTCGGGCCA	CASSLVRGSGDQYF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	42	TCRBV12						TCRBJ02	TCRBJ02-05	01	1	5	2	10	2	9	22	38	45	40	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVRGSGDQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGGACAGGGATGCCGGGGAGCTGTTTTTTGGAGAA	CSARDPDRDAGELFF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	1	3	6	3	3	26	40	51	43	54		TCRBV20-01,TCRBV20-or09_02												CSARDPDRDAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGACTAGCGGGGGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	5.155082051722657E-4		46	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	1	0	4	0	0	26	-1	-1	42	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACTCGGCAGAACCCTACACCTTCGGTTCG	CASSQDSAEPYTF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	4	5	10	5	4	26	43	51	48	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDSAEPYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTTCGGACGGGAGTCTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	5.155082051722657E-4		52	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	8	2	0	6	4	26	40	52	46	56		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*02	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGAGGGGGGGAGTGCGGGAAACACCATATATTTTGGAGAG	CASSLEGGSAGNTIYF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	1	9	0	4	1	6	26	42	50	43	56		TCRBV12-03,TCRBV12-04												CASSLEGGSAGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01*01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAAGGACTGGACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	5.155082051722657E-4		44	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	1	10	0	2	2	26	41	48	43	50		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCGACAACCAAGAGACCCAGTACTTCGGGCCA	CASSSDNQETQYF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	6	0	2	0	26	39	-1	41	45		TCRBV12-03,TCRBV12-04												CASSSDNQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGTCTAATACCCTGGGGGAGCAGTACTTCGGGCCG	CASSLASNTLGEQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	45							TCRBJ02	TCRBJ02-07	01	0	6	2	7	12	0	18	35	-1	47	51	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLASNTLGEQYF+X+TCRBJ02-07			TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGCAACAGGGTGTAGAGACCCAGTACTTCGGGCCA	CASRQQGVETQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	3	3	4	3	3	24	35	44	38	47		TCRBV24-01,TCRBV24-or09_02												CASRQQGVETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTTATGGGGCCGGGGAAAAACTGTTTTTTGGCAGT	CASSYGAGEKLFF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	7	0	8	2	4	22	35	42	37	46	TCRBV09,TCRBV12													CASSYGAGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGCGGGGGTCACAGATACGCAGTATTTTGGCCCA	CSARVAGVTDTQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	2	2	2	1	26	39	48	41	49		TCRBV20-01,TCRBV20-or09_02												CSARVAGVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGCGCGGGGGAGTTTTGGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	4.868688604404731E-4		43	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	2	7	4	7	26	39	50	43	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCTAGCGGGGGGGCCCCTTAGCACAGATACGCAGTATTTTGGCCCA	CSARALAGGPLSTDTQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	4	0	0	2	6	26	39	53	41	59		TCRBV20-01,TCRBV20-or09_02												CSARALAGGPLSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATACAGATCACCGGGGAGCTGTTTTTTGGAGAA	CSARDIQITGELFF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	3	5	4	3	2	26	40	47	43	49		TCRBV20-01,TCRBV20-or09_02												CSARDIQITGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACCGAACCGGGACAGGGGTAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	4.868688604404731E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	2	5	7	3	24	38	55	45	58	TCRBV06,TCRBV10													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGGGACTAGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	17	4.868688604404731E-4		35				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	1	8	6	0	0	24	-1	-1	35	42	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03				01,02								X+X+TCRBJ02-02		TCRBD02-01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGAGCCGGGGCCGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	4.868688604404731E-4		40	unresolved						TCRBJ02	TCRBJ02-01	01	0	7	0	9	3	2	23	40	48	43	50	TCRBV01,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAATCGGGCGGGGCTACACCTTCGGTTCG	CASSLIGRGYTF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	36	TCRBV12						TCRBJ01	TCRBJ01-02	01	2	8	0	8	3	2	26	41	48	44	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIGRGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGAATGGGTGGTTGCGGAGACCCAGTACTTCGGGCCA	CASSEWVVAETQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	42	TCRBV12						TCRBJ02	TCRBJ02-05	01	5	0	9	5	4	8	26	38	45	42	53		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEWVVAETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATGTAGCCGGGTCCGGGGAGCTGTTTTTTGGAGAA	CSVEDVAGSGELFF	In	VDJ	4	228	0.006529770598848699	0.008562737071393697	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	5	7	6	2	5	25	39	45	41	50						01,02							Vb 4	CSVEDVAGSGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGGGGGGCCCGGGAGGGGCCAACGTCCTGACTTTCGGGGCC	CSVVGGPGGANVLTF	In	VDJ	1	59	0.0016897213391757597	0.0022157959965448605	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-06	01	4	6	0	4	2	6	25	35	43	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVGGPGGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01		TCRBJ02-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGACGGGACGGTAACACTGAAGCTTTCTTTGGACAA	CSVEGRDGNTEAFF	In	VDJ	1	56	0.001603803304980382	0.0021031284035002065	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	1	0	7	2	3	3	25	38	46	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGRDGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTCGTCCGGGGAACACTGAAGCTTTCTTTGGACAA	CSVGRPGNTEAFF	In	VDJ	1	46	0.0013174098576624568	0.0017275697600180268	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	4	1	6	0	25	35	-1	41	45						01,02							Vb 4	CSVGRPGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCGGGTGAAGGGGCCCTAAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	39	0.001116934444539909		50	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	1	7	6	25	38	50	45	56													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGTAGGGCGGGGAGGACATACAATGAGCAGTTCTTCGGGCCA	CSVGRAGRTYNEQFF	In	VDJ	1	36	0.0010310164103445314	0.0013520111165358471	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	7	3	4	7	6	25	33	46	40	52						01,02							Vb 4	CSVGRAGRTYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAAAAAGGGGGCGCAACTATGGCTACACCTTCGGTTCG	CSVEKRGRNYGYTF	In	VDJ	1	31	8.878196866855686E-4	0.0011642317947947573	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	5	0	2	3	2	25	37	47	40	49													Vb 4	CSVEKRGRNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTATTCCCTAGCGGGACGACCAGTGATACGCAGTATTTTGGCCCA	CSVVFPSGTTSDTQYF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	4	3	6	6	8	25	35	50	41	58													Vb 4	CSVVFPSGTTSDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCTTGGACGGGACAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	29	8.305409972219835E-4		40	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	6	0	3	1	25	35	44	38	45													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGGTCGGGGCTTAACACTGAAGCTTTCTTTGGACAA	CSAGSGLNTEAFF	In	VDJ	1	27	7.732623077583984E-4	0.0010140083374018853	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	7	7	0	2	7	2	25	32	44	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAGSGLNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCGACAGATTATTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	26	7.44622963026606E-4		35	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	5	5	2	6	25	32	39	34	45													Vb 4	X+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGGGTGGGAGAGCACTGAAGCTTTCTTTGGACAA	CSVDGWESTEAFF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	2	4	5	2	25	36	46	41	48													Vb 4	CSVDGWESTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCCCTCGGACACTTACCGGGGAGCTGTTTTTTGGAGAA	CSVAPRTLTGELFF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	6	5	6	3	25	35	46	41	49													Vb 4	CSVAPRTLTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTTATACCTAACTATGGCTACACCTTCGGTTCG	CSVLIPNYGYTF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	5	3	7	0	5	0	25	34	-1	39	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVLIPNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAACCAACCCTTAACCTACGAGCAGTACTTCGGGCCG	CANQPLTYEQYF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	36	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	10	3	7	2	0	10	23	-1	32	30	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CANQPLTYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCGAGGGCCTGCAGGGTCGGAGACCCAGTACTTCGGGCCA	CASSRGPAGSETQYF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	45	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-05	01	5	4	3	5	10	3	23	35	50	45	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSRGPAGSETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01		TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCACCACCGACAGACTAGCCAAAAACATTCAGTACTTCGGCGCC	CATTDRLAKNIQYF	In	VDJ	1	62	0.0017756393733711373	0.0023284635895895146	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	10	2	5	0	5	3	26	33	43	38	46														CATTDRLAKNIQYF+TCRBV06-07+TCRBJ02-04	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACCCGTGAGGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASTREGANTGELFF	In	VDJ	1	44	0.0012601311681988716	0.0016524580313215908	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	5	1	0	6	0	26	36	-1	42	48														CASTREGANTGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCTCCCTAGTGGCGAGCAGTACTTCGGGCCG	CASSLPSGEQYF	In	VDJ	1	40	0.0011455737892717014	0.0015022345739287189	36	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	8	6	5	3	26	37	46	42	49						01,02								CASSLPSGEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGCTTTTCCGGGGGGAATTGAATACGCAGTATTTTGGCCCA	CASRLFRGELNTQYF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	1	7	7	6	26	37	51	44	57														CASRLFRGELNTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCGAGGGACTAGCGGATTACAATGAGCAGTTCTTCGGGCCA	CASSEGLADYNEQFF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	5	4	3	2	26	37	51	40	53						01,02								CASSEGLADYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCAGCCATGTATCGCTGTGCCTCCTTCAACGGGGTCTCTGGAAACACCATATATTTTGGAGAG	CASFNGVSGNTIYF	In	VDJ	1	32	9.164590314173611E-4	0.0012017876591429752	42	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	11	8	3	0	8	1	19	25	38	33	39														CASFNGVSGNTIYF+TCRBV07-07+TCRBJ01-03	TCRBV07-07*01	TCRBD02-01*01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTACGGGGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSYGGPTDTQYF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	42	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	1	2	1	2	19	32	40	33	42														CASSYGGPTDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCTGTGGTGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLWWVNTEAFF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	42	TCRBV07	TCRBV07-07	01				TCRBJ01	TCRBJ01-01	01	5	0	9	0	7	0	19	31	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWWVNTEAFF+TCRBV07-07+TCRBJ01-01	TCRBV07-07*01		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTGACGACAGGGTACACTGAAGCTTTCTTTGGACAA	CASSLTTGYTEAFF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	3	3	1	19	33	43	36	44														CASSLTTGYTEAFF+TCRBV07-07+TCRBJ01-01	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCAGCCATGTATCGCTGTGCTAGCAGCTTGGACAGGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	17	4.868688604404731E-4		40	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	3	2	0	0	19	-1	-1	33	41														X+TCRBV07-07+TCRBJ01-02	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGTTCAGCGCACAATGAGCAGTTCTTCGGGCCA	CASSSAHNEQFF	In	VDJ	2	85	0.0024343443022023657	0.003192248469598528	36	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	6	6	5	3	1	29	40	47	43	48			01,02			01,02								CASSSAHNEQFF+TCRBV16-01+TCRBJ02-01	TCRBV16-01	TCRBD02-01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGTAAACAGGGAGAGCAGTACTTCGGGCCG	CASSKQGEQYF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	33	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	3	7	3	1	29	40	49	43	50			01,02											CASSKQGEQYF+TCRBV16-01+TCRBJ02-07	TCRBV16-01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGGTCGTTGGCTACGAGCAGTACTTCGGGCCG	CASSEVVGYEQYF	In	VDJ	4	216	0.006186098462067188	0.008112066699215083	39	TCRBV10	unresolved					TCRBJ02	TCRBJ02-07	01	2	0	10	3	6	0	26	41	-1	47	49		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEVVGYEQYF+TCRBV10-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCGGCAGGGATGGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASGRDGDTGELFF	In	VDJ	2	86	0.0024629836469341583	0.003229804333946746	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	4	3	3	2	6	23	32	39	34	45		TCRBV06-04,TCRBV06-08												CASGRDGDTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCGGCAGAAGGAGTTGAAAAACTGTTTTTTGGCAGT	CASSDSAEGVEKLFF	In	VDJ	1	74	0.0021193115101526476	0.00277913396176813	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	10	2	7	7	1	28	45	56	52	57		TCRBV06-04,TCRBV06-08												CASSDSAEGVEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGAGAGTAATTCACCCCTCCACTTTGGGAAC	CASSEESNSPLHF	In	VDJ	1	73	0.002090672165420855	0.002741578097419912	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	11	2	6	1	0	23	39	-1	40	43		TCRBV06-01,TCRBV06-07												CASSEESNSPLHF+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCACCTTACGGGTGCTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	57	0.0016324426497121747		50	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	8	4	4	7	11	23	35	46	42	57		TCRBV06-07,TCRBV06-08				01,02								X+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTATATGACAGGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	51	0.0014606065813214193		46	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	4	4	6	22	35	46	39	52		TCRBV07-01,TCRBV07-04												X+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTCAACAGGGAAATGAGCAGTTCTTCGGGCCA	CASSQQGNEQFF	In	VDJ	1	48	0.0013746885471260417	0.0018026814887144628	36	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	3	7	2	1	23	35	43	37	44		TCRBV10-01,TCRBV10-02												CASSQQGNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCATTTTAGGGTGGTTGAGGACTGAAGCTTTCTTTGGACAA	CASILGWLRTEAFF	In	VDJ	1	44	0.0012601311681988716	0.0016524580313215908	42	TCRBV05	unresolved					TCRBJ01	TCRBJ01-01	01	6	5	3	5	4	9	19	29	37	33	46		TCRBV05-05,TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASILGWLRTEAFF+TCRBV05-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGGGGGACAGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSEGDRDTGELFF	In	VDJ	1	40	0.0011455737892717014	0.0015022345739287189	45	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	3	3	1	0	26	41	-1	42	51		TCRBV10-01,TCRBV10-02												CASSEGDRDTGELFF+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCACCGAGCGGCGGGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASTERRGGYNEQFF	In	VDJ	1	37	0.0010596557550763238	0.001389566980884065	45	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	7	0	3	7	0	23	33	-1	40	49		TCRBV10-01,TCRBV10-02												CASTERRGGYNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGGGACAGGAGGCAGGTTCACCCCTCCACTTTGGGAAC	CASSYSGQEAGSPLHF	In	VDJ	1	36	0.0010310164103445314	0.0013520111165358471	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	4	9	0	7	26	-1	51	43	58		TCRBV06-07,TCRBV06-08												CASSYSGQEAGSPLHF+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTTCCCGGGTGGTGAGACCCAGTACTTCGGGCCA	CASSDFPGGETQYF	In	VDJ	1	33	9.450983761491537E-4	0.001239343523491193	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	8	4	5	3	4	28	44	51	47	55		TCRBV06-04,TCRBV06-08				01,02								CASSDFPGGETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACCAGGCGGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSYQAETGELFF	In	VDJ	1	32	9.164590314173611E-4	0.0012017876591429752	42	TCRBV06	unresolved					TCRBJ02	TCRBJ02-02	01	2	4	4	5	0	5	23	-1	42	38	47		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYQAETGELFF+TCRBV06-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTAAAGGGGGCGGCAGGACTCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	31	8.878196866855686E-4		52	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	5	0	3	2	9	26	38	47	40	56		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAACTAGCGGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSELAGGQETQYF	In	VDJ	1	27	7.732623077583984E-4	0.0010140083374018853	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	4	0	2	0	0	23	-1	-1	38	50		TCRBV06-01,TCRBV06-07,TCRBV06-08												CASSELAGGQETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCGTTCCTGAGGGAACAAGAGACCCAGTACTTCGGGCCA	CASSYSFLREQETQYF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	11	0	2	6	2	28	45	56	51	58		TCRBV06-04,TCRBV06-08												CASSYSFLREQETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGACCCCGGGGGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRPRGPNTGELFF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	45	TCRBV06	unresolved					TCRBJ02	TCRBJ02-02	01	6	6	0	0	5	0	23	34	-1	39	45		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPRGPNTGELFF+TCRBV06-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGCTACCGGGGGGACTCAGCCTACGAGCAGTACTTCGGGCCG	CASSYRGDSAYEQYF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	1	2	4	6	28	39	50	43	56		TCRBV06-04,TCRBV06-05,TCRBV06-06												CASSYRGDSAYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGACTCAGCTGTGTAYTTYTGTGCCAGCAACGGCTGGGGACAGGGGGTTAGGGAGGGGCCCCAGGCGTGGGCTACACCTTCGGTTCG		Out	VDJ	1	21	6.014262393676433E-4		62	TCRBV12	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	12	0	1	8	12	22	8	13	36	25	58		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAACGGACTAGGGCAGATTGAAGCTTTCTTTGGACAA	CASNGLGQIEAFF	In	VDJ	1	21	6.014262393676433E-4	7.886731513125774E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	1	8	7	2	7	23	33	42	35	49		TCRBV06-07,TCRBV06-08				01,02								CASNGLGQIEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCCTAACGGGAGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSLTGGTGELFF	In	VDJ	1	20	5.727868946358507E-4	7.511172869643594E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	8	1	5	4	1	18	30	41	34	42		TCRBV07-02,TCRBV07-04												CASSLTGGTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGACAAGACTGGGAATGAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	19	5.441475499040582E-4		43	TCRBV06	unresolved					TCRBJ02	TCRBJ02-04	01	6	0	8	5	8	3	23	34	46	42	49		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-04	unresolved		TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGTTGGGGGGAGTACGGTTCAGATACGCAGTATTTTGGCCCA	CASSQGWGEYGSDTQYF	In	VDJ	2	87	0.0024916229916659505	0.0032673601982949638	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	9	1	4	3	9	23	39	48	42	57													Vb 7.1	CASSQGWGEYGSDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAAGACTCAGCCCTGTATCTCTGCACCAGCAGCCAACGGAAAAAGGCAGACCCAGTACTTCGGGCCA		Out	VDJ	1	49	0.0014033278918578343		40	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-05	01	2	1	8	6	1	7	23	38	42	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	X+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01		TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGTCCTAGCGGGGGGGAACTACGAGCAGTACTTCGGGCCG	YASSQVLAGGNYEQYF	In	VDJ	1	45	0.0012887705129306642	0.001690013895669809	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	4	0	3	2	2	22	38	52	40	54													Vb 7.1	YASSQVLAGGNYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCATAACCTAGAAACCTACAATGAGCAGTTCTTCGGGCCA	CASSHNLETYNEQFF	In	VDJ	1	43	0.0012314918234670792	0.001614902166973373	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	8	2	4	3	23	37	45	41	48						01,02							Vb 7.1	CASSHNLETYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTCCTAGCGGGGGAAGGTGAGACCCAGTACTTCGGGCCA	CASSLLAGEGETQYF	In	VDJ	1	40	0.0011455737892717014	0.0015022345739287189	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	4	2	5	2	5	23	36	48	38	53													Vb 7.1	CASSLLAGEGETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGACAGGGAAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	27	7.732623077583984E-4		41	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	3	7	0	2	23	-1	47	40	49													Vb 7.1	X+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCTGGGGCTACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	26	7.44622963026606E-4		43	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	7	0	3	3	1	23	40	48	43	49													Vb 7.1	X+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAACGTATGGGTCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	XASSQRMGRSGANVLTF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	51	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-06	01	2	0	9	0	5	3	22	37	45	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	XASSQRMGRSGANVLTF+TCRBV04-01+TCRBJ02-06	TCRBV04-01*01		TCRBJ02-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCTACGACAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPTTGNTGELFF	In	VDJ	1	21	6.014262393676433E-4	7.886731513125774E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	4	1	4	0	23	36	-1	40	46													Vb 7.1	CASSPTTGNTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAAGGCCAGGGGGTTGGTACATTGAAGCTTTCTTTGGACAA	CASSQRPGGWYIEAFF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	1	7	4	9	23	38	49	42	58													Vb 7.1	CASSQRPGGWYIEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGGCCTAGCGGCAAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRPSGKNTGELFF	In	VDJ	1	52	0.001489245926053212	0.0019529049461073347	45	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	4	5	1	2	3	26	37	46	39	49			01,02			01,02							Vb 12	CASRPSGKNTGELFF+TCRBV10-01+TCRBJ02-02	TCRBV10-01	TCRBD02-01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTATATTTCTGCGCCAGCACCCTTACCTAGCGGAGACAGGGAAAGGAGTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	38	0.0010882950998081164		58	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-01	01	7	2	3	4	15	8	23	33	55	48	63			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ02-01	TCRBV10-01		TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTAAGACAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSKTGAGELFF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	39	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	6	2	0	26	38	-1	40	48			01,02										Vb 12	CASSKTGAGELFF+TCRBV10-01+TCRBJ02-02	TCRBV10-01	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGAAAGCCCCGGGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASRKPRGGYNEQFF	In	VDJ	1	38	0.0010882950998081164	0.001427122845232283	45	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	4	7	1	22	33	48	40	49														CASRKPRGGYNEQFF+TCRBV12-01+TCRBJ02-01	TCRBV12-01*01	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATATGGGAGGGGGGACACGAAATGAGCAGTTCTTCGGGCCA	CATSRDMGGGTRNEQFF	In	VDJ	3	177	0.005069164017527279	0.006647387989634581	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	0	7	3	9	18	35	45	38	54														CATSRDMGGGTRNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTTCAAACCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	169	0.0048400492596729384		47	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	0	3	7	0	6	0	18	35	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCTCCCGGGACAGGGTGGGCGAGCAGTACTTCGGGCCG	CATSSRDRVGEQYF	In	VDJ	2	126	0.0036085574362058597	0.004732038907875465	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	6	4	4	18	30	43	34	47														CATSSRDRVGEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCATCCATTTAGCTTAGCGGAGCACAGATACGCAGTATTTTGGCCCA	CATSIHLA*RSTDTQYF	Stop	VDJ	2	90	0.0025775410258613283		51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	5	0	11	0	18	31	-1	42	48						01,02								CATSIHLA*RSTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGATCCTCCGCCGCGGGACAGGTGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	90	0.0025775410258613283		52	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	4	3	11	2	18	33	52	44	54														X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACGCAGCCATGTACCTGTGTGCCACCCGTCGGGACAGAGATACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	82	0.002348426268006988		44	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	5	3	4	4	18	27	38	31	42														X+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGATCGGGACTAGCGGGGGCAGATACGCAGTATTTTGGCCCA	CATSRSGLAGADTQYF	In	VDJ	1	78	0.002233868889079818	0.002929357419161002	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	0	2	4	2	0	18	33	-1	35	49														CATSRSGLAGADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCGTTGGTGGGGCTTAGTAATGAAAAACTGTTTTTTGGCAGT	CATSRALVGLSNEKLFF	In	VDJ	1	62	0.0017756393733711373	0.0023284635895895146	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	7	0	4	7	4	18	34	46	41	50														CATSRALVGLSNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGGACTAGCGGGGAAGAGACCCAGTACTTCGGGCCA	CATSRGTSGEETQYF	In	VDJ	1	38	0.0010882950998081164	0.001427122845232283	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	0	3	3	1	0	18	32	-1	33	46														CATSRGTSGEETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGCCCCCTAGCGGGGGGGTACTTTGGGGAGCAGTTCTTCGGGCCA	CATSRGPLAGGYFGEQFF	In	VDJ	1	31	8.878196866855686E-4	0.0011642317947947573	54	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	4	0	10	7	9	18	32	51	39	60														CATSRGPLAGGYFGEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGGTTTGCCGGCACTGAAGCTTTCTTTGGACAA	CATSRDRFAGTEAFF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	5	4	1	8	18	35	39	36	47						01,02								CATSRDRFAGTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD02-01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTGTCGAGGGTTCGGGACTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	42	0.0012028524787352866		49	TCRBV05	TCRBV05-03		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	1	8	3	2	9	0	18	33	-1	42	47			01,02											X+TCRBV05-03+TCRBJ01-03	TCRBV05-03	TCRBD02-01*02	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGAGGACGGTACAGATACGCAGTATTTTGGCCCA	CASSEDGTDTQYF	In	VDJ	1	56	0.001603803304980382	0.0021031284035002065	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-03	01	5	1	7	3	2	3	18	30	36	32	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEDGTDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01		TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGCCGGGGATTCACCCCTCCACTTTGGGAAC	CASSLAGDSPLHF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	8	3	8	0	0	18	-1	-1	35	40														CASSLAGDSPLHF+TCRBV07-02+TCRBJ01-06	TCRBV07-02*01	TCRBD02-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTGTTGATCTGGAAGACTAGCGGGGACCTCTACGAGCAGTACTTCGGGCCG	CASSLLIWKTSGDLYEQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	57	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	2	3	3	12	4	18	32	55	44	59														CASSLLIWKTSGDLYEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGGGCGCCAGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSGRQGPYEQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	42	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	2	6	1	18	30	42	36	43														CASSGRQGPYEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGAGTAGGGGGCCGCACTGAAGCTTTCTTTGGACAA	CASRVGGRTEAFF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	0	4	3	2	18	29	39	32	41														CASRVGGRTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGAAGGGGACGAGCGGGGGTATTGGGCGGGGAGCTGTTTTTTGGAGAA	CASSGRGRAGVLGGELFF	In	VDJ	4	222	0.006357934530457943	0.00833740188530439	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	6	2	7	11	7	18	30	49	41	56														CASSGRGRAGVLGGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGTGACGGGGGGGACCACAGATACGCAGTATTTTGGCCCA	CASSPVTGGTTDTQYF	In	VDJ	1	73	0.002090672165420855	0.002741578097419912	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	2	7	2	18	30	45	37	47														CASSPVTGGTTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACACGACCTTCTAGGGGAGCTGTTTTTTGGAGAA	CASSSHDLLGELFF	In	VDJ	1	67	0.0019188360970301	0.0025162429113306044	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	4	2	7	8	5	6	18	31	39	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSHDLLGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTATCCATCTGTCCCCTATGGCTACACCTTCGGTTCG	CASSLYPSVPYGYTF	In	VDJ	1	66	0.0018901967522983074	0.002478687046982386	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	3	4	6	4	5	8	18	32	39	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLYPSVPYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGGAAGGGGGGTTCGAGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	51	0.0014606065813214193		50	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	5	1	4	6	8	18	32	44	38	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGACAGGGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSWTGGANTEAFF	In	VDJ	1	44	0.0012601311681988716	0.0016524580313215908	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	1	1	0	3	18	-1	41	31	44														CASSWTGGANTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGACAGGTTGCAAAACGAGCAGTACTTCGGGCCG	CASSRDRLQNEQYF	In	VDJ	1	42	0.0012028524787352866	0.0015773463026251548	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	5	1	7	18	30	39	31	46														CASSRDRLQNEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTAGGTAACTAGCGGATAAAAGAGACCCAGTACTTCGGGCCA	CASSLGN*RIKETQYF	Stop	VDJ	1	41	0.001174213134003494		48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	3	5	3	3	4	18	34	45	37	49						01,02								CASSLGN*RIKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAAAAGGGACAGGGCGCACTGAACACTGAAGCTTTCTTTGGACAA	CASSKKGQGALNTEAFF	In	VDJ	1	41	0.001174213134003494	0.001539790438276937	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	0	5	5	18	30	44	35	49														CASSKKGQGALNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGACAGGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQGQGATNEKLFF	In	VDJ	1	39	0.001116934444539909	0.001464678709580501	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	1	0	3	0	18	30	-1	33	43														CASSQGQGATNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTCCAGGGAAGGGGATCAGCCCCAGCATTTTGGTGAT	CASSFSREGDQPQHF	In	VDJ	1	36	0.0010310164103445314	0.0013520111165358471	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	5	3	6	18	32	40	35	46														CASSFSREGDQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGAGGGACAGCTGAACACTGAAGCTTTCTTTGGACAA	CASSPEGQLNTEAFF	In	VDJ	1	31	8.878196866855686E-4	0.0011642317947947573	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	0	5	1	18	30	42	35	43														CASSPEGQLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAGGGGTAGCAAGGACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	29	8.305409972219835E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	2	3	0	9	18	-1	36	31	45														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCCGGGACGTACTCTGGAAACACCATATATTTTGGAGAG	CASSSGTYSGNTIYF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	6	0	7	0	4	3	18	29	38	33	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGTYSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATACCACAGGCTCTTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	6.873442735630209E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	4	4	4	5	18	35	44	39	49														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCTTATCCAGAGGGCTATTCACCCCTCCACTTTGGGAAC	CASSAYPEGYSPLHF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	11	0	8	9	2	18	30	44	39	46														CASSAYPEGYSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGCTTACTCCTACGAGCAGTACTTCGGGCCG	CASSLEAYSYEQYF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	9	0	0	0	3	18	-1	38	35	41														CASSLEAYSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAGGACCCTGCGGGATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	6.587049288312284E-4		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	7	3	4	8	1	18	31	45	39	46														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACACAGGGGATAGGCTACGAGCAGTACTTCGGGCCG	CASSTQGIGYEQYF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	3	2	5	18	30	39	32	44														CASSTQGIGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTCGGGGGTTAGGGGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	22	6.300655840994358E-4		44	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	4	5	1	4	8	0	18	31	-1	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGTGACACCGGGACGAGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	21	6.014262393676433E-4		53	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	3	0	7	1	9	3	18	32	46	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCAGGAGGGGGAACCTACGAGCAGTACTTCGGGCCG	CASSLPGGGTYEQYF	In	VDJ	1	19	5.441475499040582E-4	7.135614226161416E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	2	5	1	2	5	2	18	33	44	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPGGGTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCGGGGTCCAAATATGGGGGAAAAACTGTTTTTTGGCAGT	CASSFRGPNMGEKLFF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	3	8	1	13	18	32	38	33	51														CASSFRGPNMGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGAAATCACTCTTAATGAAAAACTGTTTTTTGGCAGT	CASSPEITLNEKLFF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	5	1	8	4	2	9	18	30	35	32	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPEITLNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTACGGACGCCACCTACGAGCAGTACTTCGGGCCG	CASTDATYEQYF	In	VDJ	2	94	0.0026920984047884983	0.0035302512487324898	36	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	8	1	7	2	2	4	26	35	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTDATYEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCGGGACAGGGGACCTTTGAGGGAGCAGTACTTCGGGCCG	CASGLRDRGPLREQYF	In	VDJ	1	81	0.0023197869232751953	0.003042025012205656	48	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	2	7	1	10	26	41	52	42	62														CASGLRDRGPLREQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCGTTACAGGGCCCAAATCAGCCCCAGCATTTTGGTGAT	CASGSLQGPNQPQHF	In	VDJ	1	71	0.00203339347595727	0.0026664663687234764	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	3	4	4	4	26	39	49	43	53														CASGSLQGPNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCCACGGAGCTCCTATAATGAGCAGTTCTTCGGGCCA	CASGPRSSYNEQFF	In	VDJ	1	71	0.00203339347595727	0.0026664663687234764	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	2	7	5	7	26	37	46	42	53														CASGPRSSYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTCCCCCCTCCCCATATCTACAATGAGCAGTTCTTCGGGCCA	CASGFPPPHIYNEQFF	In	VDJ	1	66	0.0018901967522983074	0.002478687046982386	48	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	3	4	6	3	10	3	26	40	52	50	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGFPPPHIYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTACTAGCGGGGACCCTTTGAGGGATACGCAGTATTTTGGCCCA	CATSGDPLRDTQYF	In	VDJ	1	55	0.0015751639602485895	0.0020655725391519886	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	4	3	6	0	11	26	-1	42	33	53														CATSGDPLRDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCCTCGACGTACTACGAGCAGTACTTCGGGCCG	CASGSSTYYEQYF	In	VDJ	1	49	0.0014033278918578343	0.0018402373530626806	39	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	4	2	7	3	4	3	26	39	46	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGSSTYYEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTACTAGTAGGGACAGTAACTATGGCTACACCTTCGGTTCG	CATSRDSNYGYTF	In	VDJ	1	49	0.0014033278918578343	0.0018402373530626806	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	5	1	6	0	26	33	-1	39	46														CATSRDSNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTAAGATTTTCCGAGCAGTACTTCGGGCCG	CASGLVRFSEQYF	In	VDJ	1	45	0.0012887705129306642	0.001690013895669809	39	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	0	2	8	6	2	5	26	43	47	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLVRFSEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTCCACCTAGGGACCGGGGAGCTGTTTTTTGGAGAA	CASGLVHLGTGELFF	In	VDJ	1	44	0.0012601311681988716	0.0016524580313215908	45	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	0	5	3	5	6	0	26	43	-1	49	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLVHLGTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGACCGATTTTGAGGCCAGCTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	38	0.0010882950998081164		47	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	9	11	1	3	9	6	26	34	47	43	53														X+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGCGCGATCGGGGGGCGCACAGATACGCAGTATTTTGGCCCA	CASAIGGRTDTQYF	In	VDJ	1	29	8.305409972219835E-4	0.0010891200660983213	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	9	8	1	1	6	1	26	34	47	40	48														CASAIGGRTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGCGCGGGTAGTAGCACAGATACGCAGTATTTTGGCCCA	CASAGSSTDTQYF	In	VDJ	1	24	6.873442735630209E-4	9.013407443572314E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	9	7	4	0	1	4	26	34	40	35	44						01,02								CASAGSSTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATAAGCAGCGACCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQ*AATSSYNEQFF	Stop	VDJ	2	84	0.002405704957470573		51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	6	0	4	5	20	36	44	40	49						01,02								CASSQ*AATSSYNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTACCCGCCTGGCGGGACAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	67	0.0019188360970301		52	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-02	01	6	0	6	1	13	0	20	31	-1	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01		TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGAGCCCTGACAGGGGGACTCTATAATTCACCCCTCCACTTTGGGAAC	CASRALTGGLYNSPLHF	In	VDJ	1	66	0.0018901967522983074	0.002478687046982386	51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	1	3	6	3	20	31	46	37	49														CASRALTGGLYNSPLHF+TCRBV23-01+TCRBJ01-06	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GAGACACGGCACTGTATCTCTGCGCCAGCTACCGGGGCCCCCAAGAGACCCAGTACTTCGGGCCA	CASYRGPQETQYF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	8	7	0	1	4	2	20	29	38	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASYRGPQETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGGGATCCAGGGTCGACGAGCAGTACTTCGGGCCG	CASSQGSRVDEQYF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	3	5	1	11	20	31	37	32	48														CASSQGSRVDEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTTAATCGTGGACAGGGGGTTTATGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	5.155082051722657E-4		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	1	9	2	5	20	37	49	39	54														X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTCAGGACAGAATTCACCCCTCCACTTTGGGAAC	CASSSGQNSPLHF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	5	7	4	0	20	31	-1	35	41														CASSSGQNSPLHF+TCRBV23-01+TCRBJ01-06	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCACCCCCCAGATATGGGGGATACGCAGTATTTTGGCCCA	CASSHPPDMGDTQYF	In	VDJ	20	1121	0.03210470544433943	0.04210012393435235	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	6	2	6	14	0	23	35	-1	49	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHPPDMGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTTACCTGACAGCGAACACTGAAGCTTTCTTTGGACAA	CASSVYLTANTEAFF	In	VDJ	6	352	0.010081049345590972	0.013219664250572727	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	1	8	1	23	35	48	43	49														CASSVYLTANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACGGGACAGTCAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSYTGQSSSYNSPLHF	In	VDJ	3	157	0.004496377122891428	0.005896270702670222	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	0	5	0	2	5	23	38	47	40	52														CASSYTGQSSSYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCACCAAATCAGCCCCAGCATTTTGGTGAT	CASSYSPNQPQHF	In	VDJ	3	151	0.004324541054500673	0.0056709355165809145	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	0	3	7	4	0	2	23	-1	42	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSPNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGACAACAATGAGCAGTTCTTCGGGCCA	CASSDSDNNEQFF	In	VDJ	3	144	0.004124065641378126	0.0054080444661433885	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	6	5	0	0	23	-1	-1	40	45														CASSDSDNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTAGGGGCGCTTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	137	0.003923590228255578		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	5	2	4	0	4	23	-1	44	39	48														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCCCCTACGAGCAGTACTTCGGGCCG	CASSYTPYEQYF	In	VDJ	2	127	0.0036371967809376523	0.004769594772223683	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	3	7	2	0	2	23	-1	40	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGCGGACTAGCGGGGGTCATCTCCTACGAGCAGTACTTCGGGCCG	CASSRGLAGVISYEQYF	In	VDJ	2	122	0.0034940000572786893	0.004581815450482593	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	0	3	4	23	35	51	38	55														CASSRGLAGVISYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGCTGAGCAAGAGACCCAGTACTTCGGGCCA	CASSYQAEQETQYF	In	VDJ	2	103	0.0029498525073746312	0.0038682540278664516	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	4	2	0	5	23	-1	42	38	47														CASSYQAEQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGACAGGGAGAGAGAGACCCAGTACTTCGGGCCA	CAISDRERETQYF	In	VDJ	2	83	0.0023770656127387805	0.003117136740902092	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	4	1	4	23	34	42	35	46														CAISDRERETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGGACTAGCGGGGGGTTCCAGTTCTTCGGGCCA	CASSYSGTSGGFQFF	In	VDJ	1	73	0.002090672165420855	0.002741578097419912	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	0	1	13	1	3	23	40	56	41	59														CASSYSGTSGGFQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGCTCCGGTAGGGGGTTCCACTGAAGCTTTCTTTGGACAA	CATAPVGGSTEAFF	In	VDJ	1	73	0.002090672165420855	0.002741578097419912	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	5	1	4	10	3	23	30	46	40	49														CATAPVGGSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCACGAACCGGACAGGGCAGGCGAGCAGTACTTCGGGCCG	CASSHEPDRAGEQYF	In	VDJ	1	65	0.0018615574075665148	0.0024411311826341682	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	3	6	9	4	23	34	51	43	55														CASSHEPDRAGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGGGTTGGGATCGGGGAGCTGTTTTTTGGAGAA	CASSRVGIGELFF	In	VDJ	1	64	0.0018329180628347222	0.0024035753182859504	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	3	7	0	7	23	-1	39	34	46														CASSRVGIGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACGGGTCGGGGTATTCACCCCTCCACTTTGGGAAC	CASSYDGSGYSPLHF	In	VDJ	1	63	0.0018042787181029299	0.0023660194539377325	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	2	8	3	8	7	1	23	38	50	45	51														CASSYDGSGYSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTGCTAGCGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSPASGTYNEQFF	In	VDJ	1	60	0.0017183606839075523	0.0022533518608930784	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	3	2	4	0	23	35	-1	39	48														CASSPASGTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTACTAGCGGGGGTCGGCGGGGAGCTGTTTTTTGGAGAA	CASSLLAGVGGELFF	In	VDJ	1	59	0.0016897213391757597	0.0022157959965448605	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	3	2	7	2	4	23	35	48	37	52														CASSLLAGVGGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACAAAGAGCGGGGACAGGGAGCCACGAGCAGTACTTCGGGCCG	CASRQRAGTGSHEQYF	In	VDJ	1	57	0.0016324426497121747	0.0021406842678484243	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	5	10	4	23	34	53	44	57														CASRQRAGTGSHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGAGGAGGGGAAGGACACAGATACGCAGTATTTTGGCCCA	CASEEGKDTDTQYF	In	VDJ	1	53	0.0015178852707850045	0.001990460810455553	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	10	0	2	2	6	23	32	40	34	46														CASEEGKDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCGTTCGGGACTAGCGCAGAATTAGGGGGGGACCCAGTACTTCGGGCCA		Out	VDJ	1	52	0.001489245926053212		55	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	6	7	7	14	23	34	51	41	65						01,02								X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGGGTAGCGGGGGGCTTAATGAGCAGTTCTTCGGGCCA	CASSAGSGGLNEQFF	In	VDJ	1	51	0.0014606065813214193	0.0019153490817591166	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	1	7	5	3	23	35	50	40	53														CASSAGSGGLNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTATCCCGGGAGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLSREAGELFF	In	VDJ	1	51	0.0014606065813214193	0.0019153490817591166	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	8	1	6	7	0	23	34	-1	41	48														CASSLSREAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGGGGCGGGGCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYRGRGSSYNEQFF	In	VDJ	1	49	0.0014033278918578343	0.0018402373530626806	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	2	6	0	0	1	7	23	38	45	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRGRGSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCTAGCGACAGGGCTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	48	0.0013746885471260417		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	3	6	3	23	34	47	40	50														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTAGCGGGGGCCCAGATACGCAGTATTTTGGCCCA	CASSDSSGGPDTQYF	In	VDJ	1	44	0.0012601311681988716	0.0016524580313215908	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	5	2	4	0	2	23	-1	49	40	51														CASSDSSGGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCAGTAGCGGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSDSVAGGYNEQFF	In	VDJ	1	44	0.0012601311681988716	0.0016524580313215908	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	1	3	2	0	23	40	-1	42	52														CASSDSVAGGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTTAAACTCCCTCGCTAACTATGGCTACACCTTCGGTTCG	CASRLNSLANYGYTF	In	VDJ	1	42	0.0012028524787352866	0.0015773463026251548	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	3	10	0	5	6	23	34	42	39	48						01,02								CASRLNSLANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACAGCTCGATCCTACGAGCAGTACTTCGGGCCG	CASSYGTARSYEQYF	In	VDJ	1	39	0.001116934444539909	0.001464678709580501	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	5	1	0	5	23	-1	45	38	50														CASSYGTARSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAGACAGCAGCAGGCTCACCCCTCCACTTTGGGAAC	CASSETAAGSPLHF	In	VDJ	1	39	0.001116934444539909	0.001464678709580501	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	5	10	3	8	23	34	42	37	50														CASSETAAGSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAATAATCCCTGGACATTCAGTACTTCGGCGCC	CASS**SLDIQYF	Stop	VDJ	1	38	0.0010882950998081164		39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-04	01	3	0	10	8	9	0	23	37	-1	46	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASS**SLDIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01		TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCAGGGGAAAATTCACCCCTCCACTTTGGGAAC	CASSAGENSPLHF	In	VDJ	1	38	0.0010882950998081164	0.001427122845232283	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	2	7	1	2	23	35	42	36	44														CASSAGENSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCGGGTCCCAGAAGCAGTACTTCGGGCCG	CASRPGSQKQYF	In	VDJ	1	38	0.0010882950998081164	0.001427122845232283	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	8	4	8	3	7	23	34	41	37	48						01,02								CASRPGSQKQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACTCGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSYDSSSGNTIYF	In	VDJ	1	37	0.0010596557550763238	0.001389566980884065	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	2	10	0	0	4	23	-1	42	38	46						01,02								CASSYDSSSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGAGGGCATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	35	0.0010023770656127388		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	11	0	0	0	2	23	-1	42	37	44														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGCGCAGGGAGGTTACAATGAGCAGTTCTTCGGGCCA	CASSDSAQGGYNEQFF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	1	4	6	1	23	40	52	46	53														CASSDSAQGGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATTCCCAGGGGGCCAGAGAATTCACCCCTCCACTTTGGGAAC	CASSIPRGPENSPLHF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	0	7	5	5	23	35	48	40	53														CASSIPRGPENSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGGGGGTTCGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGGSDTGELFF	In	VDJ	1	34	9.737377208809462E-4	0.0012768993878394112	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	8	1	3	0	5	23	-1	43	36	48														CASSSGGSDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAAACCGGGACAAAACTATGGCTACACCTTCGGTTCG	CASRKPGQNYGYTF	In	VDJ	1	33	9.450983761491537E-4	0.001239343523491193	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	6	2	6	1	23	34	46	40	47														CASRKPGQNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGAGGGCCGGAGCCAGAGCGAGCAGTACTTCGGGCCG	CASSLEGRSQSEQYF	In	VDJ	1	32	9.164590314173611E-4	0.0012017876591429752	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	0	6	1	12	23	36	43	37	55														CASSLEGRSQSEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYSDSNQPQHF	In	VDJ	1	32	9.164590314173611E-4	0.0012017876591429752	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	0	1	8	0	0	0	23	-1	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCGAGACAGTCTATGGCTACACCTTCGGTTCG	CASSYTETVYGYTF	In	VDJ	1	32	9.164590314173611E-4	0.0012017876591429752	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	5	4	5	1	23	38	48	43	49														CASSYTETVYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCGACAGGGGGTAGACGAAAAACTGTTTTTTGGCAGT	CATRQGVDEKLFF	In	VDJ	1	32	9.164590314173611E-4	0.0012017876591429752	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	2	1	8	3	5	23	30	42	33	47														CATRQGVDEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGAGATTCACCCCTCCACTTTGGGAAC	CASSYGDSPLHF	In	VDJ	1	31	8.878196866855686E-4	0.0011642317947947573	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	2	10	2	8	0	0	23	-1	-1	38	42														CASSYGDSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAAGACAGGGGGCAAGGATCACCCCTCCACTTTGGGAAC	CASSQDRGQGSPLHF	In	VDJ	1	31	8.878196866855686E-4	0.0011642317947947573	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	0	10	4	5	23	34	48	38	53														CASSQDRGQGSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTTCACGGACCCCCACGAGCAGTACTTCGGGCCG	CASSYSFTDPHEQYF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	1	7	5	6	4	23	40	50	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSFTDPHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTACAGGGCACTGAAGCTTTCTTTGGACAA	CASSYLQGTEAFF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	4	2	0	23	38	-1	40	46														CASSYLQGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGTGTCAGAGGGGAAGAGACCCAGTACTTCGGGCCA	CASSYSVRGEETQYF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	2	5	2	3	8	0	23	38	-1	46	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSVRGEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGACGGGTTCAGCGGGCCTGGATATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	8.305409972219835E-4		58	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	4	1	14	8	23	35	55	49	63						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTAGGACAGGGGAGTGGACAGATACGCAGTATTTTGGCCCA	CAISRTGEWTDTQYF	In	VDJ	1	28	8.01901652490191E-4	0.0010515642017501032	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	2	3	1	5	23	35	45	36	50														CAISRTGEWTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGCTAGCGGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSWLAGGYNEQFF	In	VDJ	1	28	8.01901652490191E-4	0.0010515642017501032	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	4	1	3	2	0	23	36	-1	38	49														CASSWLAGGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGAGGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSYEGATNEKLFF	In	VDJ	1	28	8.01901652490191E-4	0.0010515642017501032	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	5	1	0	2	0	23	37	-1	39	45														CASSYEGATNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCGGACACCCGAACACTGAAGCTTTCTTTGGACAA	CASSAGHPNTEAFF	In	VDJ	1	28	8.01901652490191E-4	0.0010515642017501032	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	6	1	3	3	23	35	43	38	46														CASSAGHPNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTCCGACAGAACTCTGGAAACACCATATATTTTGGAGAG	CASSYFRQNSGNTIYF	In	VDJ	1	26	7.44622963026606E-4	9.764524730536674E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	2	5	0	3	2	23	39	47	42	49														CASSYFRQNSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTTAGCGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLADTGELFF	In	VDJ	1	26	7.44622963026606E-4	9.764524730536674E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	5	5	3	2	0	23	34	-1	36	42						01,02								CASSLADTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGAGGGACAGGGCTATGGGACGAGCAGTACTTCGGGCCG	CAIRGTGLWDEQYF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	5	1	7	23	34	44	35	51														CAIRGTGLWDEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATATCTGACCCGACGGATACGCAGTATTTTGGCCCA	CAISDPTDTQYF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	10	2	7	6	5	6	23	30	38	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDPTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGTAAACGGGAGCTGTTTTTTGGAGAA	CASSYGKRELFF	In	VDJ	1	25	7.159836182948135E-4	9.388966087054494E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	2	0	10	9	0	5	23	-1	40	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGKRELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTGATACGGGGGATAAGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	24	6.873442735630209E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	8	2	7	6	5	23	36	48	42	53														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCCCAATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	23	6.587049288312284E-4		38	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	2	7	4	0	5	23	-1	38	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTTCCTTCCCGACTAGAAAAAACGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	6.587049288312284E-4		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	8	6	10	7	23	35	51	45	58						01,02								X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACACTACAGGGAAGTTCCATCAGCGAGCAGTTCTTCGGGCCA	CASSTLQGSSISEQFF	In	VDJ	1	23	6.587049288312284E-4	8.637848800090134E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	10	6	13	23	34	46	40	59														CASSTLQGSSISEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGGCGAAATGGCTACACCTTCGGTTCG	CASSYGGRNGYTF	In	VDJ	1	22	6.300655840994358E-4	8.262290156607954E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	6	0	6	1	3	23	38	45	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGGRNGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAGGGGGGACAGGGAGAGTTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	22	6.300655840994358E-4		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	3	9	4	4	23	37	50	41	54														X+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
TTGTGTGCCAGCAGTGGGATTGGAGGGGGAGGGAAAGGGGACGCCGGAAGCAAAGAAAAACTGTTTTTTGGCAGT	CASSGIGGGGKGDAGSKEKLFF	In	VDJ	1	21	6.014262393676433E-4	7.886731513125774E-4	66	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	9	0	8	11	21	3	15	33	26	54														CASSGIGGGGKGDAGSKEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTCGAGCGGGGACAACAGATACGCAGTATTTTGGCCCA	CASSFRAGTTDTQYF	In	VDJ	1	21	6.014262393676433E-4	7.886731513125774E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	3	3	4	3	23	36	47	40	50														CASSFRAGTTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGACAGGTAGGTCCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	21	6.014262393676433E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	1	4	2	0	6	23	-1	43	36	49														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGAAAACAGGGCTAAAGTCCCTACGAGCAGTACTTCGGGCCG	CAIRKQG*SPYEQYF	Stop	VDJ	1	20	5.727868946358507E-4		45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	3	2	3	8	23	34	43	37	51														CAIRKQG*SPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCGGGGGTAGCCAAAAACATTCAGTACTTCGGCGCC	CASAGVAKNIQYF	In	VDJ	1	20	5.727868946358507E-4	7.511172869643594E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	8	7	2	0	0	1	23	-1	39	32	40														CASAGVAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCCTCCCCTTGGGACAGGGGTTCGGAAAGACCCAGTACTTCGGGCCA	CALPLGQGFGKTQYF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	11	0	2	6	8	7	23	29	47	37	54														CALPLGQGFGKTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGACAGGGGCCTCGATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	5.155082051722657E-4		55	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	2	0	0	6	23	-1	50	40	56														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCATCTTCGGCAGTGAACAAGAGACCCAGTACTTCGGGCCA	CASTIFGSEQETQYF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	7	4	5	2	10	4	23	33	46	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTIFGSEQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGAAGACAGGGGACTATGGCTACACCTTCGGTTCG	CASKKTGDYGYTF	In	VDJ	1	18	5.155082051722657E-4	6.760055582679236E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	2	3	4	0	23	33	-1	37	45														CASKKTGDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGCTTGGAGCGGGGGGGCTTGGAGATACGCAGTATTTTGGCCCA	CASSRLGAGGLGDTQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	0	5	8	5	23	35	53	43	58														CASSRLGAGGLGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACTACTAGCGGGGGCAAACAAGAGACCCAGTACTTCGGGCCA	CASRTTSGGKQETQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	3	2	2	4	4	23	34	49	38	53														CASRTTSGGKQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGCCGGACAGAACTCCTACGAGCAGTACTTCGGGCCG	CATAGQNSYEQYF	In	VDJ	1	17	4.868688604404731E-4	6.384496939197056E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	1	5	0	5	2	23	30	41	35	43														CATAGQNSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGATCTAGGCTCTGGAAACACCATATATTTTGGAGAG	CASSPDLGSGNTIYF	In	VDJ	4	213	0.00610018042787181	0.00799939910617043	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	4	8	0	3	1	24	39	46	42	47						01,02							Vb 18	CASSPDLGSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD02-01	TCRBJ01-03*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGACAGGGTCTAGGAGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	159	0.004553655812355013		47	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	4	0	10	24	-1	45	37	55													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCTCGACACAGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLDTAGANVLTF	In	VDJ	3	150	0.00429590170976888	0.005633379652232696	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	2	6	2	4	3	24	35	43	39	46													Vb 18	CASSLDTAGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTTGGGAGGGGTTAATGAAAAACTGTTTTTTGGCAGT	CASSPLGGVNEKLFF	In	VDJ	2	121	0.0034653607125468967	0.004544259586134375	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	9	0	4	3	2	24	38	48	41	50													Vb 18	CASSPLGGVNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACTTTGGGGGAGCAGTACTTCGGGCCG	CASSPTLGEQYF	In	VDJ	2	113	0.003236245954692557	0.004243812671348631	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	2	6	2	7	5	0	24	39	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTLGEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPSATNEKLFF	In	VDJ	2	112	0.003207606609960764	0.004206256807000413	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	5	0	1	0	24	39	-1	40	43													Vb 18	CASSPSATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGGGATCCCGGGGGAGCAGTACTTCGGGCCG	CASSGIPGEQYF	In	VDJ	2	95	0.002720737749520291	0.0035678071130807077	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	8	3	7	8	0	24	35	-1	43	48						01,02							Vb 18	CASSGIPGEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTACCCCTCCCAGGGCAAGACACTGAAGCTTTCTTTGGACAA	CASSPLPLPGQDTEAFF	In	VDJ	1	68	0.0019474754417618924	0.0025537987756788223	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	3	10	4	24	39	54	49	58													Vb 18	CASSPLPLPGQDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGGGTTTTGACACTGAAGCTTTCTTTGGACAA	CASSPGGFDTEAFF	In	VDJ	1	50	0.001431967236589627	0.0018777932174108987	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	1	3	0	5	24	-1	44	38	49													Vb 18	CASSPGGFDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCCCCGATACCATACGAGCAGTACTTCGGGCCG	CASSPSPIPYEQYF	In	VDJ	1	50	0.001431967236589627	0.0018777932174108987	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	2	2	8	4	5	5	24	39	46	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPSPIPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGACGGAGCCCCTACGAGCAGTACTTCGGGCCG	CASSPGRSPYEQYF	In	VDJ	1	49	0.0014033278918578343	0.0018402373530626806	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	3	1	7	2	1	6	24	38	43	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGRSPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCACCTACACGGGGGGCAGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	47	0.0013460492023942491		40	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	10	8	1	4	6	4	24	31	44	37	48													Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCATCGGACAGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPIGQAGANVLTF	In	VDJ	1	43	0.0012314918234670792	0.001614902166973373	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	4	2	4	0	24	38	-1	42	49													Vb 18	CASSPIGQAGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTCGACAATAGCGAAAACATTCAGTACTTCGGCGCC	CASSPFDNSENIQYF	In	VDJ	1	42	0.0012028524787352866	0.0015773463026251548	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	5	6	5	8	0	24	39	-1	47	52						01,02							Vb 18	CASSPFDNSENIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01	TCRBJ02-04*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAACTAGGGGGCTAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	40	0.0011455737892717014		52	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	0	0	5	3	24	41	53	46	56													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGAAAGGAGACCCAGTACTTCGGGCCA	CASSPGKETQYF	In	VDJ	1	36	0.0010310164103445314	0.0013520111165358471	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	2	1	8	5	0	3	24	-1	42	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGKETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGACAGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPDRSSYNEQFF	In	VDJ	1	35	0.0010023770656127388	0.001314455252187629	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	4	0	1	2	24	38	45	39	47													Vb 18	CASSPDRSSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGCGGGACGGTCCTACGAGCAGTACTTCGGGCCG	CASSPAGRSYEQYF	In	VDJ	1	34	9.737377208809462E-4	0.0012768993878394112	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	3	1	1	3	24	38	45	39	48													Vb 18	CASSPAGRSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTCAGATAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSPSDSSYNSPLHF	In	VDJ	1	30	8.591803419537761E-4	0.0011266759304465392	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-06	01	3	4	5	0	2	4	24	38	43	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPSDSSYNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01		TCRBJ01-06*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTTCCGTCTAGGGGGCGAACAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	7.732623077583984E-4		53	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	5	0	2	8	4	24	40	55	48	59													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3328B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				833	635	175	22	0	661	512	136	13	0	34917	26627	7344	946	0	0.0572692491	8.48457718	0.058255028	8.82274342				78950	0.007774899869229949	0.0421001241	0.0321047045	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:57	Age (Range):45-65 Years (Late Adulthood),Age:56 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,overall survival (days):overall survival (days) 1300,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 183,type of chemo:carbo/taxol	0.7623049011910831	MSKCC- Snyder- P01-02		614.0	
